data_1v28_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1v28 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.5 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -91.3 -169.71 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.24 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 111.017 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.05 55.03 4.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.273 1.7 m-85 -98.49 120.13 38.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.452 -1.028 . . . . 0.0 108.907 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.71 128.41 44.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.413 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.42 122.09 10.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' GLY . 1.9 p -89.94 147.93 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.56 -27.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' THR . 26.0 m-20 -70.12 -4.27 20.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 81.8 37.36 16.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.4 mtp-105 -133.17 163.14 29.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.729 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.2 m -95.96 121.28 37.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.563 -0.71 . . . . 0.0 110.024 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.9 mttm -127.91 131.71 23.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.002 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.75 124.73 9.95 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.746 1.393 . . . . 0.0 111.672 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.489 1.481 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 -179.724 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.3 m . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.142 0.496 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -86.59 -170.21 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.67 -97.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 111.145 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.09 54.58 2.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.279 2.1 m-85 -97.87 119.3 36.23 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.565 -0.962 . . . . 0.0 109.095 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -99.16 123.6 43.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.945 -1.097 . . . . 0.0 110.342 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -46.82 133.96 10.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.378 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.49 ' CG2' ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -100.9 151.28 21.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.8 -29.64 0.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.552 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -70.99 -3.72 21.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.87 40.24 10.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.2 mtp85 -134.67 162.0 33.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.429 -1.042 . . . . 0.0 110.679 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -94.59 129.59 41.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.42 -0.8 . . . . 0.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.49 ' HE2' ' CG2' ' A' ' 14' ' ' THR . 2.0 tmmm? -134.29 131.11 20.45 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 109.934 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.3 Cg_endo -73.98 138.89 26.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.789 1.415 . . . . 0.0 111.638 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 121.203 0.525 . . . . 0.0 110.351 -179.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.2 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.186 0.517 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -90.08 -170.54 2.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.221 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.85 -98.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.41 -0.806 . . . . 0.0 111.093 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.6 54.96 3.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.285 1.8 m-85 -98.29 117.62 33.1 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.596 -0.944 . . . . 0.0 109.318 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.3 128.67 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 110.117 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.2 mmt180 -51.62 121.63 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 110.283 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 18' ' ' ARG . 8.3 t -89.84 149.45 22.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.56 -27.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.655 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.53 -5.95 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.09 41.68 8.47 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 29.3 mmt180 -139.9 161.72 36.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -1.184 . . . . 0.0 110.688 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 77.7 m -89.93 116.78 28.24 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.482 -0.761 . . . . 0.0 109.718 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' MET . 59.9 tttt -122.7 130.28 24.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 110.35 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.5 Cg_endo -71.72 130.43 16.98 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.814 1.429 . . . . 0.0 111.634 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.586 -179.388 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 95.7 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.285 0.564 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -83.86 -169.95 2.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.963 . . . . 0.0 110.322 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.41 -97.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.983 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.65 54.07 4.08 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.683 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.6 m-85 -98.02 121.19 39.65 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.431 -1.04 . . . . 0.0 108.966 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.3 ttm -99.04 128.38 45.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 130.29 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 15' ' ' ALA . 63.3 p -94.7 145.53 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.98 -29.01 0.3 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.795 . . . . 0.0 110.603 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.81 -13.73 62.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.09 42.61 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 23.3 mtt180 -138.65 156.64 47.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.805 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -92.7 123.46 36.0 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.1 ttpt -127.67 130.67 23.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.8 Cg_endo -72.71 130.17 15.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.684 1.36 . . . . 0.0 112.055 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 -179.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 93.1 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.357 0.599 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -75.99 -168.48 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.64 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.4 -0.813 . . . . 0.0 110.758 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.35 56.58 2.04 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.667 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.276 1.6 m-85 -98.03 120.48 38.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.482 -1.011 . . . . 0.0 109.092 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.11 132.48 44.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 0.0 110.281 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.88 126.21 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.502 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 41.9 p -89.86 149.92 22.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.943 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -42.81 -30.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.633 -0.667 . . . . 0.0 110.802 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -14.76 62.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.075 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.03 3.43 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 33.5 mtp180 -137.04 154.92 50.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -1.174 . . . . 0.0 110.77 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 71.4 m -89.79 118.2 29.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.259 -0.901 . . . . 0.0 110.099 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 10.5 tttt -122.61 130.53 24.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.019 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.667 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.0 Cg_endo -71.06 130.34 17.6 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.647 1.341 . . . . 0.0 111.639 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.303 -1.438 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.28 -179.227 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.597 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -81.8 -172.49 3.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -42.2 -98.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.432 -0.793 . . . . 0.0 111.133 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.95 52.81 4.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.276 1.9 m-85 -98.41 118.27 34.71 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -1.022 . . . . 0.0 109.139 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.6 ttt -99.12 118.27 35.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.118 . . . . 0.0 110.123 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.5 tpp85 -43.48 127.87 4.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 110.303 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.489 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 30.6 p -92.0 146.13 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.46 -26.57 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -9.6 55.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.021 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.55 43.06 5.3 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.7 mtp-105 -142.13 159.74 41.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 0.0 110.756 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -91.23 121.25 32.82 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.508 -0.745 . . . . 0.0 109.93 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.4 OUTLIER -130.0 133.55 25.11 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 110.049 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.665 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.2 Cg_endo -73.69 138.63 26.78 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.805 1.424 . . . . 0.0 111.642 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 -178.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 83.9 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.225 0.536 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.609 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -96.01 -172.05 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.91 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 111.079 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.23 55.4 2.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.68 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.279 1.9 m-85 -98.26 120.83 39.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.494 -1.004 . . . . 0.0 108.811 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.3 tpp -99.22 121.23 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 110.31 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -50.27 128.47 19.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 p -89.78 145.99 24.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.856 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.05 -29.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.66 -13.95 62.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.421 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 96.53 47.13 2.39 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.5 mmt180 -141.19 154.11 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 81.1 m -91.67 123.53 35.13 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.622 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.8 mttt -131.51 131.54 22.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.7 Cg_endo -74.59 139.41 25.4 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.812 1.427 . . . . 0.0 111.797 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.239 -179.377 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.1 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.158 0.504 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -83.59 -170.82 3.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 110.167 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.04 -97.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.419 -0.801 . . . . 0.0 111.0 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.9 3.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.7 m-85 -98.78 121.11 40.3 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.449 -1.03 . . . . 0.0 109.394 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.17 133.36 43.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 0.0 110.081 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -58.3 126.52 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.342 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 20' ' ' LYS . 1.2 p -90.22 150.38 22.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.87 -30.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -69.85 -9.54 55.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.054 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 89.32 42.33 5.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 8.1 mmm180 -135.36 157.59 46.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -1.108 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.62 117.52 29.81 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 109.95 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 12' ' ' MET . 26.1 mttt -124.71 132.09 24.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.661 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.74 132.57 20.42 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.764 1.402 . . . . 0.0 111.752 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.671 -179.089 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 92.7 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.261 0.553 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB2' ' CG ' ' A' ' 11' ' ' PHE . . . -93.78 -171.67 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.266 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.0 -96.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.481 -0.762 . . . . 0.0 111.046 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.47 3.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.273 1.7 m-85 -98.11 117.21 31.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.479 -1.013 . . . . 0.0 109.089 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' LYS . 2.6 tpt -98.99 123.63 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.983 -1.073 . . . . 0.0 110.115 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.57 128.58 8.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.455 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -90.8 147.35 23.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.99 -29.12 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -0.75 . . . . 0.0 110.615 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -13.45 62.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.9 41.79 3.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 6.3 mtt180 -139.16 160.0 40.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.135 -1.215 . . . . 0.0 110.712 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 73.9 m -89.2 120.12 30.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.236 -0.915 . . . . 0.0 110.002 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 12' ' ' MET . 66.7 tttt -126.76 130.66 23.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 110.235 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.48 138.53 29.92 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.64 1.337 . . . . 0.0 111.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.488 1.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.617 -178.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.0 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.246 0.546 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.596 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -88.42 -170.31 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.64 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.826 . . . . 0.0 111.033 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.48 55.45 2.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.676 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.282 1.8 m-85 -98.39 119.81 37.72 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.468 -1.019 . . . . 0.0 109.246 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -98.75 130.1 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.86 -1.15 . . . . 0.0 110.206 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.2 mmt180 -54.55 124.3 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 110.05 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.99 151.31 20.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.91 -27.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.54 -6.46 31.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.854 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.21 41.25 8.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 10.7 mtp180 -140.19 161.85 36.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -1.086 . . . . 0.0 110.847 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.29 127.32 36.68 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' MET . 18.1 ttpp -132.49 132.07 22.58 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.912 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.9 Cg_endo -74.04 139.63 27.27 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.698 1.367 . . . . 0.0 111.842 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.298 -179.314 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 84.7 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -81.01 -168.91 1.99 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.31 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.41 -97.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 111.002 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.92 54.51 3.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.283 1.6 m-85 -97.87 119.33 36.28 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.522 -0.987 . . . . 0.0 109.066 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -98.95 136.51 38.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.935 -1.103 . . . . 0.0 110.407 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.05 127.61 33.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -89.62 151.56 21.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.12 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 110.872 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -69.81 -11.92 61.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 0.0 110.169 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 93.55 46.96 3.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 71.1 mtp85 -137.97 155.79 48.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.277 -1.131 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -89.74 121.14 31.62 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.5 tttp -127.09 131.37 23.82 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.938 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.92 138.59 28.78 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.667 1.351 . . . . 0.0 111.831 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.247 0.546 . . . . 0.0 110.253 -179.468 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.214 0.531 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.76 -169.27 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.54 -98.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.417 -0.802 . . . . 0.0 111.096 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.39 56.06 2.39 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.286 2.1 m-85 -97.66 122.68 41.02 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.528 -0.984 . . . . 0.0 109.3 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.7 ttt -99.26 131.2 45.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.97 -1.081 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.68 126.81 28.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -93.9 144.57 25.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.33 -0.856 . . . . 0.0 109.922 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.9 -27.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 -6.96 35.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 87.16 48.55 4.3 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 3.0 mmm180 -147.88 160.9 42.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -1.12 . . . . 0.0 110.78 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.3 m -96.06 126.92 41.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.559 -0.713 . . . . 0.0 109.894 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 28.1 tttp -129.4 130.44 23.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -72.6 135.35 23.87 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.616 1.324 . . . . 0.0 111.892 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.184 -179.641 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.449 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 96.8 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.218 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.591 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -99.21 -171.54 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.19 -98.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 111.155 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -87.75 53.76 4.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.271 1.9 m-85 -98.14 118.99 35.99 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.459 -1.024 . . . . 0.0 109.049 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.5 ttp -99.16 114.17 26.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 110.292 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.16 127.36 4.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 110.096 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 16' ' ' ASP . 1.2 p -89.6 143.94 26.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.69 -27.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.699 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.75 -16.51 63.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.993 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 18' ' ' ARG . . . 99.2 40.14 3.33 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 mmt-85 -137.88 156.26 48.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -1.201 . . . . 0.0 110.777 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.97 118.27 30.22 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.539 -0.726 . . . . 0.0 110.103 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 12' ' ' MET . 1.1 mmtt -126.84 130.83 23.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.6 Cg_endo -72.92 135.88 24.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.816 1.429 . . . . 0.0 111.814 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.488 1.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.27 -179.461 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.0 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.24 0.543 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -82.26 -169.73 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.63 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.525 -0.734 . . . . 0.0 110.893 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.54 56.35 1.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.282 1.9 m-85 -98.12 118.01 33.78 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.457 -1.025 . . . . 0.0 109.222 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -98.95 125.74 44.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 110.12 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.56 126.75 8.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.848 . . . . 0.0 110.592 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.3 m -90.28 144.11 26.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.11 -26.79 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.838 . . . . 0.0 110.346 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-20 -70.56 -9.62 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.29 47.03 3.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 7.2 mtt180 -147.54 160.13 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.684 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.07 123.87 34.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.7 tttp -130.23 133.62 25.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 109.868 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.4 Cg_endo -73.63 137.04 24.43 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.833 1.438 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 121.311 0.576 . . . . 0.0 110.411 -179.412 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.4 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.174 0.511 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB1' ' CG ' ' A' ' 11' ' ' PHE . . . -87.5 -171.23 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.78 -97.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 111.056 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.12 54.2 4.24 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.267 1.8 m-85 -98.42 119.09 36.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.402 -1.058 . . . . 0.0 108.939 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -99.06 120.4 39.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 110.406 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -43.62 127.58 4.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 110.294 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -93.12 148.04 22.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.03 -27.49 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.327 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -8.21 47.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 86.69 38.36 8.17 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 17' ' ' GLY . 2.3 mmm-85 -134.7 159.45 41.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -1.015 . . . . 0.0 110.605 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.6 m -90.71 122.51 33.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.423 -0.798 . . . . 0.0 109.793 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -129.56 131.0 23.31 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.092 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.671 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.5 Cg_endo -73.45 134.35 20.51 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.787 1.414 . . . . 0.0 111.603 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.488 1.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.469 -179.26 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.0 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.177 0.513 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -71.12 -174.66 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.26 -99.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.454 -0.779 . . . . 0.0 111.334 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.86 54.39 4.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.67 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.278 1.9 m-85 -98.64 118.65 35.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.513 -0.992 . . . . 0.0 109.489 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.1 ttt -99.28 125.89 45.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 110.244 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.79 133.44 4.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 110.312 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -95.08 149.59 21.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.738 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.13 -35.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 17.1 p30 -69.41 -8.31 45.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.143 -0.973 . . . . 0.0 110.406 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.53 46.31 4.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -138.11 162.92 32.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -1.182 . . . . 0.0 110.504 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -91.68 119.98 32.03 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.288 -0.882 . . . . 0.0 109.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -129.06 131.49 23.75 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 110.068 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.49 134.6 22.75 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.666 1.351 . . . . 0.0 111.795 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 22' ' ' THR . 7.6 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.425 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 89.8 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.08 0.467 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.63 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -90.05 -170.1 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.983 . . . . 0.0 110.346 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.73 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.469 -0.769 . . . . 0.0 111.155 -179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.56 53.97 4.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.655 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.269 1.8 m-85 -98.03 116.7 30.77 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 108.942 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -99.01 126.39 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 110.435 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -47.55 125.46 8.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.432 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' OD1' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.8 147.24 23.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.64 -29.41 0.49 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.506 -0.746 . . . . 0.0 110.685 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 25.6 p30 -70.1 -9.54 55.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.15 -0.969 . . . . 0.0 110.04 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 90.08 47.76 3.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.1 mtp85 -146.04 164.0 33.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.182 -1.187 . . . . 0.0 110.624 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.34 118.5 29.88 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.456 -0.777 . . . . 0.0 110.264 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -124.59 127.89 25.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.981 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.0 Cg_endo -72.82 135.42 23.52 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.831 1.437 . . . . 0.0 111.967 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.197 -179.527 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 91.2 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.224 0.535 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -79.09 -170.53 2.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.11 -98.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.521 -0.737 . . . . 0.0 111.231 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.62 55.34 3.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.277 1.7 m-85 -98.24 118.81 35.72 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.589 -0.948 . . . . 0.0 109.171 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.5 tpp -99.48 126.76 45.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.989 -1.069 . . . . 0.0 110.341 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -51.58 120.59 5.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 110.065 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -89.69 146.89 24.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.05 -25.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.499 -0.751 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -69.27 -7.69 39.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 109.801 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 85.04 47.18 5.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -149.58 161.01 43.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -1.129 . . . . 0.0 110.762 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 77.5 m -89.96 118.07 29.25 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.52 -0.738 . . . . 0.0 109.902 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 14.8 tmtt? -123.46 130.47 24.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.114 -0.991 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.671 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.99 138.32 30.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.803 1.423 . . . . 0.0 111.809 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--N 1.302 -1.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.321 -179.424 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 68.9 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.241 0.543 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -81.7 -171.99 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.108 -0.995 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.74 -97.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.433 -0.792 . . . . 0.0 111.111 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.43 55.43 2.76 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.28 2.0 m-85 -98.73 119.88 38.22 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.498 -1.001 . . . . 0.0 109.408 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -98.99 121.88 41.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.997 -1.065 . . . . 0.0 110.255 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.1 mmt180 -46.01 127.61 8.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.444 HG21 ' HB2' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -91.98 146.27 23.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.895 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.73 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.404 -0.81 . . . . 0.0 110.522 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 8.4 m-20 -69.86 -9.93 56.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.97 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.33 5.3 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.5 mtp180 -142.57 160.94 39.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -1.227 . . . . 0.0 110.697 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.75 124.39 35.85 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.428 -0.795 . . . . 0.0 110.466 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.4 tttp -132.01 134.28 24.99 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.704 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.03 123.27 8.75 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.85 1.447 . . . . 0.0 111.436 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 -179.272 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 74.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.41 0.624 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -89.6 -168.19 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.534 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.04 -97.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.59 -0.694 . . . . 0.0 111.016 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.5 55.42 3.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.279 1.8 m-85 -98.01 119.17 36.16 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.479 -1.012 . . . . 0.0 109.014 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.2 ttm -99.14 131.23 45.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 110.356 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -52.5 125.14 15.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 110.302 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -89.89 146.35 24.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.12 -28.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 -2.73 21.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 83.4 48.67 5.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.4 mtt85 -144.85 162.65 36.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -1.193 . . . . 0.0 110.721 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -95.35 120.71 36.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.426 -0.797 . . . . 0.0 109.831 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' MET . 15.5 tttp -126.61 131.56 23.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.102 -0.999 . . . . 0.0 110.128 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.2 Cg_endo -73.07 133.53 19.84 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.772 1.406 . . . . 0.0 111.492 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.191 0.52 . . . . 0.0 110.541 -179.368 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.9 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.297 0.57 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.591 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -71.32 -170.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.28 -94.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.37 -0.831 . . . . 0.0 110.714 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.48 54.18 3.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.7 m-85 -98.23 119.91 37.73 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.447 -1.031 . . . . 0.0 108.743 179.838 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -99.11 121.42 40.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 0.0 110.711 -179.056 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.73 122.73 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.248 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 147.67 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.882 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.25 -27.71 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.6 -6.42 31.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.8 42.84 6.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.8 mmt85 -142.4 162.43 35.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.155 . . . . 0.0 110.411 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 71.6 m -95.25 119.47 33.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -122.64 131.26 24.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.165 -0.959 . . . . 0.0 110.157 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.1 Cg_endo -71.74 132.51 20.32 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.808 1.425 . . . . 0.0 111.776 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 22' ' ' THR . 15.3 p . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.337 0.589 . . . . 0.0 110.273 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.196 0.522 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.581 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -84.47 -169.4 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.383 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.67 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.452 -0.78 . . . . 0.0 111.061 -179.571 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.38 55.49 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.278 2.3 m-85 -97.74 120.49 38.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.534 -0.98 . . . . 0.0 109.144 -179.736 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.4 ttp -99.14 123.47 43.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.003 -1.061 . . . . 0.0 110.432 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.11 130.27 15.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 110.3 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -99.34 143.92 29.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.71 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.558 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 11.5 t0 -69.74 -10.85 59.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 110.028 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 43.4 4.95 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -142.56 158.22 43.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -1.099 . . . . 0.0 110.66 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -93.49 119.17 32.24 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.467 -0.77 . . . . 0.0 109.734 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -123.15 130.83 24.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.65 139.79 31.56 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.856 1.451 . . . . 0.0 111.987 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 10' ' ' GLY . 12.1 p . . . . . 0 C--N 1.303 -1.449 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 99.3 m . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.164 0.507 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.78 -170.73 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.023 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.86 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.009 -179.543 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.07 55.31 2.17 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.283 2.0 m-85 -98.12 118.37 34.59 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.486 -1.008 . . . . 0.0 109.243 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.26 123.98 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.32 -179.565 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.518 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.04 131.65 7.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.008 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 32.2 p -100.28 149.12 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.02 -28.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.508 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -7.31 38.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 84.35 43.97 6.77 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG3' ' C ' ' A' ' 17' ' ' GLY . 62.3 mtp85 -142.78 161.36 38.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -1.054 . . . . 0.0 110.808 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.2 m -89.87 126.09 35.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.473 -0.767 . . . . 0.0 109.925 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' MET . 15.0 ttpp -131.63 130.89 22.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.9 Cg_endo -73.59 132.96 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.695 1.366 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 22' ' ' THR . 9.3 p . . . . . 0 C--N 1.302 -1.478 0 CA-C-O 121.295 0.569 . . . . 0.0 110.236 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.3 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -90.07 -169.24 2.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 110.182 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.58 -95.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.349 -0.845 . . . . 0.0 110.764 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.79 54.41 3.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.684 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.7 m-85 -98.13 124.5 42.71 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.379 -1.071 . . . . 0.0 108.767 179.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.1 ttp -99.13 138.63 35.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 110.342 -179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.51 124.39 23.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 110.207 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.1 p -89.77 146.62 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.819 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.71 -28.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.692 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' THR . 80.6 m-20 -69.76 -13.33 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.81 40.66 4.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.9 mmt180 -134.91 155.66 50.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -1.175 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.8 m -94.59 125.98 39.58 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.601 -0.687 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 129.0 23.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.684 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.54 135.53 24.32 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.657 1.346 . . . . 0.0 111.937 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 22' ' ' THR . 10.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.295 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 87.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HB3' ' CG ' ' A' ' 11' ' ' PHE . . . -93.61 -171.63 2.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.27 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.39 -97.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.4 -0.812 . . . . 0.0 111.035 -179.63 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -89.28 53.86 3.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.669 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.9 m-85 -98.55 118.93 36.35 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.427 -1.043 . . . . 0.0 109.066 -179.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.88 122.85 42.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.016 . . . . 0.0 110.367 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.24 128.41 9.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 110.269 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.416 HG22 ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -89.7 143.88 26.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.834 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.87 -28.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.545 -0.722 . . . . 0.0 110.689 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -69.88 -18.92 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 110.123 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.93 43.87 2.01 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 20.8 mtp85 -141.05 162.57 35.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.222 -1.163 . . . . 0.0 110.761 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -94.14 119.66 33.28 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -128.3 132.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.669 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.38 134.7 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.852 1.449 . . . . 0.0 111.723 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 121.27 0.557 . . . . 0.0 110.401 -179.218 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.446 ' O ' ' OE1' ' A' ' 1' ' ' GLU . 2.5 pp20? . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.244 0.545 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 106.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -162.9 117.11 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.7 14.86 4.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.219 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.62 -149.82 18.69 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.11 61.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.5 m -106.25 176.89 5.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 110.186 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -91.3 -169.71 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.24 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 111.017 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.05 55.03 4.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.273 1.7 m-85 -98.49 120.13 38.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.452 -1.028 . . . . 0.0 108.907 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.71 128.41 44.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.413 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.42 122.09 10.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 17' ' ' GLY . 1.9 p -89.94 147.93 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.56 -27.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' THR . 26.0 m-20 -70.12 -4.27 20.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 81.8 37.36 16.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.4 mtp-105 -133.17 163.14 29.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.729 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.2 m -95.96 121.28 37.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.563 -0.71 . . . . 0.0 110.024 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.9 mttm -127.91 131.71 23.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.002 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.75 124.73 9.95 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.746 1.393 . . . . 0.0 111.672 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 p -67.1 -19.39 65.63 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' ASN . 9.2 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.214 0.531 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' GLU . 65.2 t30 55.28 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.844 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 2' ' ' ASN . 3.2 t80 64.99 64.46 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 179.82 61.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.51 115.77 7.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 173.07 156.46 12.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.3 m -142.18 -176.14 4.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -1.165 . . . . 0.0 110.388 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -86.59 -170.21 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.67 -97.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 111.145 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.09 54.58 2.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.279 2.1 m-85 -97.87 119.3 36.23 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.565 -0.962 . . . . 0.0 109.095 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -99.16 123.6 43.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.945 -1.097 . . . . 0.0 110.342 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -46.82 133.96 10.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.378 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.49 ' CG2' ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -100.9 151.28 21.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.8 -29.64 0.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.552 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -70.99 -3.72 21.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.87 40.24 10.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.2 mtp85 -134.67 162.0 33.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.429 -1.042 . . . . 0.0 110.679 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 76.6 m -94.59 129.59 41.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.42 -0.8 . . . . 0.0 110.018 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.49 ' HE2' ' CG2' ' A' ' 14' ' ' THR . 2.0 tmmm? -134.29 131.11 20.45 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 109.934 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.3 Cg_endo -73.98 138.89 26.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.789 1.415 . . . . 0.0 111.638 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 p -79.54 -1.12 36.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.203 0.525 . . . . 0.0 110.351 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.358 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 1.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.257 0.551 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -126.45 164.48 21.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -89.54 171.77 9.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.073 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.07 149.82 40.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.193 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.16 -130.64 6.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -79.25 90.75 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.2 m -141.87 -173.55 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.181 . . . . 0.0 110.161 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -90.08 -170.54 2.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.221 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.85 -98.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.41 -0.806 . . . . 0.0 111.093 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.6 54.96 3.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.285 1.8 m-85 -98.29 117.62 33.1 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.596 -0.944 . . . . 0.0 109.318 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.3 128.67 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 110.117 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.2 mmt180 -51.62 121.63 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 110.283 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 18' ' ' ARG . 8.3 t -89.84 149.45 22.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.56 -27.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.655 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.53 -5.95 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.09 41.68 8.47 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 29.3 mmt180 -139.9 161.72 36.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -1.184 . . . . 0.0 110.688 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 77.7 m -89.93 116.78 28.24 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.482 -0.761 . . . . 0.0 109.718 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' MET . 59.9 tttt -122.7 130.28 24.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 110.35 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.5 Cg_endo -71.72 130.43 16.98 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.814 1.429 . . . . 0.0 111.634 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 23' ' ' PHE . 28.0 p -62.5 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.586 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 32.1 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.224 0.535 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 49.2 73.35 0.24 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.18 104.29 4.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.368 -0.832 . . . . 0.0 110.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.21 140.51 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.093 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.87 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.47 77.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 95.7 m -120.78 169.95 9.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -1.107 . . . . 0.0 110.051 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -83.86 -169.95 2.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.963 . . . . 0.0 110.322 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.41 -97.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.983 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.65 54.07 4.08 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.683 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.6 m-85 -98.02 121.19 39.65 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.431 -1.04 . . . . 0.0 108.966 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.3 ttm -99.04 128.38 45.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 130.29 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 15' ' ' ALA . 63.3 p -94.7 145.53 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.98 -29.01 0.3 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.795 . . . . 0.0 110.603 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.81 -13.73 62.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.09 42.61 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 23.3 mtt180 -138.65 156.64 47.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.805 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -92.7 123.46 36.0 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.1 ttpt -127.67 130.67 23.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.8 Cg_endo -72.71 130.17 15.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.684 1.36 . . . . 0.0 112.055 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 23' ' ' PHE . 29.2 p -60.52 -92.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' N ' ' OG1' ' A' ' 22' ' ' THR . 18.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 110.226 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 32.0 mm-40 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.222 0.534 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.2 t30 63.86 142.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 140.37 57.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.63 51.91 1.43 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.859 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.81 157.31 45.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -163.03 89.62 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 93.1 m -123.42 164.54 18.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.157 . . . . 0.0 110.673 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -75.99 -168.48 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.64 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.4 -0.813 . . . . 0.0 110.758 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.35 56.58 2.04 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.667 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.276 1.6 m-85 -98.03 120.48 38.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.482 -1.011 . . . . 0.0 109.092 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.11 132.48 44.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 0.0 110.281 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.88 126.21 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.502 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 41.9 p -89.86 149.92 22.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.943 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -42.81 -30.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.633 -0.667 . . . . 0.0 110.802 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -14.76 62.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.075 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.03 3.43 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 33.5 mtp180 -137.04 154.92 50.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -1.174 . . . . 0.0 110.77 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 71.4 m -89.79 118.2 29.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.259 -0.901 . . . . 0.0 110.099 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 10.5 tttt -122.61 130.53 24.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.019 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.667 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.0 Cg_endo -71.06 130.34 17.6 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.647 1.341 . . . . 0.0 111.639 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 p -78.47 -15.92 58.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.28 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.224 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 3' ' ' PHE . 2.2 mp0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.65 67.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -147.75 97.05 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.236 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' PHE . . . 48.87 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.965 . . . . 0.0 110.217 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.79 -147.1 4.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 99.03 134.57 8.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m -139.53 -179.87 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -1.168 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.597 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -81.8 -172.49 3.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -42.2 -98.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.432 -0.793 . . . . 0.0 111.133 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.95 52.81 4.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.276 1.9 m-85 -98.41 118.27 34.71 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -1.022 . . . . 0.0 109.139 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.6 ttt -99.12 118.27 35.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.118 . . . . 0.0 110.123 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.5 tpp85 -43.48 127.87 4.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 110.303 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.489 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 30.6 p -92.0 146.13 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.46 -26.57 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -9.6 55.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.021 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.55 43.06 5.3 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.7 mtp-105 -142.13 159.74 41.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 0.0 110.756 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 80.8 m -91.23 121.25 32.82 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.508 -0.745 . . . . 0.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.4 OUTLIER -130.0 133.55 25.11 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 110.049 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.665 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.2 Cg_endo -73.69 138.63 26.78 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.805 1.424 . . . . 0.0 111.642 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -83.19 42.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.232 0.539 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -113.98 69.2 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.454 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER 59.66 169.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.359 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 3' ' ' PHE . . . 65.81 155.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.235 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.02 78.61 1.38 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.95 168.23 39.63 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 83.9 m -146.08 -159.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -1.121 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.609 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -96.01 -172.05 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.91 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 111.079 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.23 55.4 2.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.68 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.279 1.9 m-85 -98.26 120.83 39.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.494 -1.004 . . . . 0.0 108.811 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.3 tpp -99.22 121.23 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 110.31 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -50.27 128.47 19.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 p -89.78 145.99 24.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.856 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.05 -29.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.66 -13.95 62.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.421 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 96.53 47.13 2.39 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.5 mmt180 -141.19 154.11 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 81.1 m -91.67 123.53 35.13 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.622 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.8 mttt -131.51 131.54 22.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.7 Cg_endo -74.59 139.41 25.4 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.812 1.427 . . . . 0.0 111.797 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 p -80.8 -35.52 32.91 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.239 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.156 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 2.3 mt-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 2.5 t-20 65.04 135.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.05 120.87 3.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.23 -19.32 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 13' ' ' ARG . . . -57.35 -35.34 71.02 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -49.0 160.94 0.68 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.1 m -133.11 177.1 7.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.011 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -83.59 -170.82 3.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 110.167 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.04 -97.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.419 -0.801 . . . . 0.0 111.0 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.9 3.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.7 m-85 -98.78 121.11 40.3 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.449 -1.03 . . . . 0.0 109.394 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.17 133.36 43.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 0.0 110.081 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -58.3 126.52 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.342 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 20' ' ' LYS . 1.2 p -90.22 150.38 22.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.87 -30.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -69.85 -9.54 55.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.054 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 89.32 42.33 5.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 8.1 mmm180 -135.36 157.59 46.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -1.108 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 78.2 m -91.62 117.52 29.81 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 109.95 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 12' ' ' MET . 26.1 mttt -124.71 132.09 24.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.661 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.74 132.57 20.42 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.764 1.402 . . . . 0.0 111.752 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 p -71.78 -27.14 62.75 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.671 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 110.246 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.416 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 3.8 mm-40 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 1.5 m-20 -120.94 138.53 54.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -160.38 61.25 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 0.0 110.091 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.95 135.62 52.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.83 157.6 17.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -129.77 63.17 0.63 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 92.7 m -145.76 -168.8 3.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB2' ' CG ' ' A' ' 11' ' ' PHE . . . -93.78 -171.67 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.266 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.0 -96.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.481 -0.762 . . . . 0.0 111.046 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.47 3.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.273 1.7 m-85 -98.11 117.21 31.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.479 -1.013 . . . . 0.0 109.089 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' LYS . 2.6 tpt -98.99 123.63 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.983 -1.073 . . . . 0.0 110.115 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.57 128.58 8.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.455 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -90.8 147.35 23.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.99 -29.12 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -0.75 . . . . 0.0 110.615 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -13.45 62.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.9 41.79 3.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 6.3 mtt180 -139.16 160.0 40.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.135 -1.215 . . . . 0.0 110.712 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 73.9 m -89.2 120.12 30.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.236 -0.915 . . . . 0.0 110.002 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 12' ' ' MET . 66.7 tttt -126.76 130.66 23.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 110.235 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.48 138.53 29.92 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.64 1.337 . . . . 0.0 111.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -76.63 -3.7 39.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.617 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.3 t80 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.234 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 56.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.23 0.538 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.0 OUTLIER 174.91 134.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.316 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -114.7 145.39 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.212 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 175.99 46.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.45 -111.39 0.05 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.04 68.01 3.06 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.0 m -134.13 -175.27 3.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.385 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.596 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -88.42 -170.31 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.64 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.826 . . . . 0.0 111.033 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.48 55.45 2.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.676 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.282 1.8 m-85 -98.39 119.81 37.72 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.468 -1.019 . . . . 0.0 109.246 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -98.75 130.1 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.86 -1.15 . . . . 0.0 110.206 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.2 mmt180 -54.55 124.3 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 110.05 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.99 151.31 20.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.91 -27.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.54 -6.46 31.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.854 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.21 41.25 8.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 10.7 mtp180 -140.19 161.85 36.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -1.086 . . . . 0.0 110.847 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.29 127.32 36.68 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' MET . 18.1 ttpp -132.49 132.07 22.58 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.912 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.9 Cg_endo -74.04 139.63 27.27 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.698 1.367 . . . . 0.0 111.842 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.1 p -78.73 65.75 4.05 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.298 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.126 179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.207 0.527 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' PHE . 31.2 t-20 -130.74 93.2 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ASN . 2.0 t80 43.05 70.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.5 -163.19 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -117.23 5.71 17.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 146.6 18.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 84.7 m -111.96 170.17 8.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.352 -1.087 . . . . 0.0 110.139 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -81.01 -168.91 1.99 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.31 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.41 -97.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 111.002 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.92 54.51 3.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.283 1.6 m-85 -97.87 119.33 36.28 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.522 -0.987 . . . . 0.0 109.066 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.434 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -98.95 136.51 38.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.935 -1.103 . . . . 0.0 110.407 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.05 127.61 33.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -89.62 151.56 21.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.12 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 110.872 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -69.81 -11.92 61.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 0.0 110.169 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 93.55 46.96 3.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 71.1 mtp85 -137.97 155.79 48.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.277 -1.131 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -89.74 121.14 31.62 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.5 tttp -127.09 131.37 23.82 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.938 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.92 138.59 28.78 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.667 1.351 . . . . 0.0 111.831 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 p -72.02 -30.35 65.12 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.247 0.546 . . . . 0.0 110.253 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.201 0.524 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -125.55 75.95 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ASN . 11.2 m-85 51.63 177.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.64 -23.84 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.059 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.25 166.07 40.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.45 157.27 22.71 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.5 m -124.77 173.03 8.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.015 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.76 -169.27 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.54 -98.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.417 -0.802 . . . . 0.0 111.096 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.39 56.06 2.39 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.286 2.1 m-85 -97.66 122.68 41.02 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.528 -0.984 . . . . 0.0 109.3 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.7 ttt -99.26 131.2 45.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.97 -1.081 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.68 126.81 28.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -93.9 144.57 25.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.33 -0.856 . . . . 0.0 109.922 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.9 -27.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 -6.96 35.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 87.16 48.55 4.3 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 3.0 mmm180 -147.88 160.9 42.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -1.12 . . . . 0.0 110.78 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.3 m -96.06 126.92 41.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.559 -0.713 . . . . 0.0 109.894 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 28.1 tttp -129.4 130.44 23.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -72.6 135.35 23.87 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.616 1.324 . . . . 0.0 111.892 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 p -70.49 -19.38 62.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.184 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.19 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.239 0.542 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -79.31 57.84 2.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.272 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 59.17 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.69 143.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.272 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.88 90.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -164.71 155.32 26.64 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.449 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 96.8 m -139.76 -166.99 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.194 . . . . 0.0 110.294 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.591 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -99.21 -171.54 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.19 -98.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 111.155 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -87.75 53.76 4.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.271 1.9 m-85 -98.14 118.99 35.99 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.459 -1.024 . . . . 0.0 109.049 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.5 ttp -99.16 114.17 26.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 110.292 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.16 127.36 4.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 110.096 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 16' ' ' ASP . 1.2 p -89.6 143.94 26.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.69 -27.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.699 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.75 -16.51 63.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.993 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 18' ' ' ARG . . . 99.2 40.14 3.33 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 mmt-85 -137.88 156.26 48.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -1.201 . . . . 0.0 110.777 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 66.0 m -90.97 118.27 30.22 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.539 -0.726 . . . . 0.0 110.103 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 12' ' ' MET . 1.1 mmtt -126.84 130.83 23.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.6 Cg_endo -72.92 135.88 24.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.816 1.429 . . . . 0.0 111.814 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.0 p -72.2 56.16 0.33 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.27 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 t80 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.254 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.232 0.539 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -154.64 172.18 18.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.947 . . . . 0.0 110.369 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -50.77 168.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.33 -0.856 . . . . 0.0 110.389 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.36 68.15 1.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.119 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.79 -24.72 9.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.08 83.92 0.47 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.0 m -126.3 176.91 6.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -82.26 -169.73 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.63 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.525 -0.734 . . . . 0.0 110.893 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.54 56.35 1.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.282 1.9 m-85 -98.12 118.01 33.78 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.457 -1.025 . . . . 0.0 109.222 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -98.95 125.74 44.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 110.12 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.56 126.75 8.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.848 . . . . 0.0 110.592 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.3 m -90.28 144.11 26.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.11 -26.79 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.838 . . . . 0.0 110.346 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-20 -70.56 -9.62 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.29 47.03 3.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 7.2 mtt180 -147.54 160.13 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.684 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.07 123.87 34.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.7 tttp -130.23 133.62 25.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 109.868 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.4 Cg_endo -73.63 137.04 24.43 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.833 1.438 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.1 p -78.01 -31.52 50.61 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.311 0.576 . . . . 0.0 110.411 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.31 0.576 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 2' ' ' ASN . 13.2 p30 -123.19 -176.64 3.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -106.62 98.65 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.06 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.34 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.366 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.98 -144.39 4.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.73 41.24 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.4 m -120.74 178.92 4.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -1.125 . . . . 0.0 110.222 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB1' ' CG ' ' A' ' 11' ' ' PHE . . . -87.5 -171.23 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.78 -97.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 111.056 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.12 54.2 4.24 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.267 1.8 m-85 -98.42 119.09 36.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.402 -1.058 . . . . 0.0 108.939 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -99.06 120.4 39.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 110.406 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -43.62 127.58 4.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 110.294 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -93.12 148.04 22.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.03 -27.49 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.327 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -8.21 47.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 86.69 38.36 8.17 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 17' ' ' GLY . 2.3 mmm-85 -134.7 159.45 41.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -1.015 . . . . 0.0 110.605 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.6 m -90.71 122.51 33.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.423 -0.798 . . . . 0.0 109.793 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.5 OUTLIER -129.56 131.0 23.31 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.092 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.671 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.5 Cg_endo -73.45 134.35 20.51 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.787 1.414 . . . . 0.0 111.603 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 p -74.18 -25.39 59.68 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.469 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' OXT' ' CG ' ' A' ' 23' ' ' PHE . 12.1 t80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.182 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.213 0.53 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -124.32 74.8 1.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -64.58 159.12 22.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.16 119.38 10.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.04 -117.3 4.37 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' A' ' 7' ' ' CYS . . . 105.5 169.01 23.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.0 m -150.39 -174.56 4.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -1.124 . . . . 0.0 110.133 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -71.12 -174.66 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.26 -99.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.454 -0.779 . . . . 0.0 111.334 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.86 54.39 4.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.67 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.278 1.9 m-85 -98.64 118.65 35.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.513 -0.992 . . . . 0.0 109.489 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.1 ttt -99.28 125.89 45.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 110.244 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.79 133.44 4.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 110.312 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -95.08 149.59 21.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.738 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.13 -35.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 17.1 p30 -69.41 -8.31 45.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.143 -0.973 . . . . 0.0 110.406 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.53 46.31 4.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -138.11 162.92 32.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -1.182 . . . . 0.0 110.504 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -91.68 119.98 32.03 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.288 -0.882 . . . . 0.0 109.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -129.06 131.49 23.75 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 110.068 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.49 134.6 22.75 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.666 1.351 . . . . 0.0 111.795 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 22' ' ' THR . 7.6 p -74.7 78.09 2.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.425 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.302 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.208 0.528 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.53 147.52 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.253 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -144.92 103.96 3.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.22 155.43 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.21 133.56 7.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 126.46 143.83 5.97 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 89.8 m -131.0 179.75 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -1.165 . . . . 0.0 110.091 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.63 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -90.05 -170.1 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.983 . . . . 0.0 110.346 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.73 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.469 -0.769 . . . . 0.0 111.155 -179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.56 53.97 4.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.655 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.269 1.8 m-85 -98.03 116.7 30.77 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 108.942 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -99.01 126.39 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 110.435 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -47.55 125.46 8.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.432 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' OD1' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.8 147.24 23.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.64 -29.41 0.49 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.506 -0.746 . . . . 0.0 110.685 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 25.6 p30 -70.1 -9.54 55.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.15 -0.969 . . . . 0.0 110.04 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 90.08 47.76 3.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.1 mtp85 -146.04 164.0 33.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.182 -1.187 . . . . 0.0 110.624 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 64.6 m -90.34 118.5 29.88 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.456 -0.777 . . . . 0.0 110.264 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -124.59 127.89 25.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.981 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.0 Cg_endo -72.82 135.42 23.52 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.831 1.437 . . . . 0.0 111.967 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.9 p -72.3 -14.42 61.75 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.197 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.2 179.95 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.177 0.513 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 2' ' ' ASN . 8.2 p30 -153.29 74.35 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -87.87 161.31 17.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.918 . . . . 0.0 110.171 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.76 105.54 6.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.47 -63.4 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -178.05 52.2 0.1 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 91.2 m -133.18 171.72 13.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -1.169 . . . . 0.0 110.235 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -79.09 -170.53 2.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.11 -98.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.521 -0.737 . . . . 0.0 111.231 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.62 55.34 3.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.277 1.7 m-85 -98.24 118.81 35.72 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.589 -0.948 . . . . 0.0 109.171 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.5 tpp -99.48 126.76 45.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.989 -1.069 . . . . 0.0 110.341 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -51.58 120.59 5.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 110.065 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -89.69 146.89 24.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.05 -25.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.499 -0.751 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -69.27 -7.69 39.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 109.801 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 85.04 47.18 5.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -149.58 161.01 43.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -1.129 . . . . 0.0 110.762 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 77.5 m -89.96 118.07 29.25 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.52 -0.738 . . . . 0.0 109.902 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 14.8 tmtt? -123.46 130.47 24.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.114 -0.991 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.671 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.99 138.32 30.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.803 1.423 . . . . 0.0 111.809 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -69.78 -25.37 63.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.321 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.199 179.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.289 0.566 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -156.22 113.18 3.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.96 125.7 38.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.195 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.06 -92.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.361 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.9 -128.17 1.22 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 100.77 77.07 1.25 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 68.9 m -145.32 -178.18 5.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -1.127 . . . . 0.0 110.033 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -81.7 -171.99 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.108 -0.995 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.74 -97.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.433 -0.792 . . . . 0.0 111.111 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.43 55.43 2.76 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.28 2.0 m-85 -98.73 119.88 38.22 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.498 -1.001 . . . . 0.0 109.408 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -98.99 121.88 41.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.997 -1.065 . . . . 0.0 110.255 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.1 mmt180 -46.01 127.61 8.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 HG21 ' HB2' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -91.98 146.27 23.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.895 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.73 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.404 -0.81 . . . . 0.0 110.522 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 8.4 m-20 -69.86 -9.93 56.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.97 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.33 5.3 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.5 mtp180 -142.57 160.94 39.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -1.227 . . . . 0.0 110.697 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 80.3 m -91.75 124.39 35.85 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.428 -0.795 . . . . 0.0 110.466 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.4 tttp -132.01 134.28 24.99 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.704 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.03 123.27 8.75 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.85 1.447 . . . . 0.0 111.436 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 15.7 p -67.43 -24.57 65.65 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 22' ' ' THR . 10.4 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.217 0.532 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 55.02 95.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.115 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.66 125.92 30.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.85 178.59 8.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.133 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.47 72.04 1.27 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -112.02 159.5 13.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 74.6 m -122.48 171.94 8.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.183 . . . . 0.0 110.446 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -89.6 -168.19 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.534 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.04 -97.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.59 -0.694 . . . . 0.0 111.016 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.5 55.42 3.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.279 1.8 m-85 -98.01 119.17 36.16 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.479 -1.012 . . . . 0.0 109.014 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.2 ttm -99.14 131.23 45.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 110.356 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -52.5 125.14 15.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 110.302 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -89.89 146.35 24.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.12 -28.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 -2.73 21.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 83.4 48.67 5.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.4 mtt85 -144.85 162.65 36.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -1.193 . . . . 0.0 110.721 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 82.1 m -95.35 120.71 36.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.426 -0.797 . . . . 0.0 109.831 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' MET . 15.5 tttp -126.61 131.56 23.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.102 -0.999 . . . . 0.0 110.128 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.2 Cg_endo -73.07 133.53 19.84 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.772 1.406 . . . . 0.0 111.492 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.1 p -66.44 -34.9 78.98 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.191 0.52 . . . . 0.0 110.541 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.256 179.961 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.296 0.569 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.24 171.09 14.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -107.15 66.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.8 169.06 4.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.321 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.41 -138.92 4.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 171.38 110.47 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.9 m -127.16 161.74 27.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.591 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -71.32 -170.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.28 -94.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.37 -0.831 . . . . 0.0 110.714 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.48 54.18 3.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.7 m-85 -98.23 119.91 37.73 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.447 -1.031 . . . . 0.0 108.743 179.838 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -99.11 121.42 40.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 0.0 110.711 -179.056 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.73 122.73 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.248 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 147.67 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.882 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.25 -27.71 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.6 -6.42 31.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.8 42.84 6.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.8 mmt85 -142.4 162.43 35.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.155 . . . . 0.0 110.411 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 71.6 m -95.25 119.47 33.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -122.64 131.26 24.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.165 -0.959 . . . . 0.0 110.157 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.1 Cg_endo -71.74 132.51 20.32 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.808 1.425 . . . . 0.0 111.776 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' OG1' ' A' ' 22' ' ' THR . 15.3 p -67.93 91.54 0.34 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.337 0.589 . . . . 0.0 110.273 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.237 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.228 0.537 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -176.11 4.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.195 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.28 107.76 1.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.83 68.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 110.151 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.08 -115.12 4.04 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.53 39.9 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.0 m -138.24 -179.26 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.059 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -84.47 -169.4 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.383 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.67 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.452 -0.78 . . . . 0.0 111.061 -179.571 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.38 55.49 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.278 2.3 m-85 -97.74 120.49 38.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.534 -0.98 . . . . 0.0 109.144 -179.736 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.4 ttp -99.14 123.47 43.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.003 -1.061 . . . . 0.0 110.432 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.11 130.27 15.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 110.3 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -99.34 143.92 29.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.71 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.558 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 11.5 t0 -69.74 -10.85 59.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 110.028 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.34 43.4 4.95 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -142.56 158.22 43.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -1.099 . . . . 0.0 110.66 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -93.49 119.17 32.24 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.467 -0.77 . . . . 0.0 109.734 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -123.15 130.83 24.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.65 139.79 31.56 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.856 1.451 . . . . 0.0 111.987 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 10' ' ' GLY . 12.1 p -71.64 -30.26 65.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.36 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.178 179.963 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -113.24 114.9 27.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.228 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -177.24 156.0 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.175 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.55 69.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.05 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.75 134.07 6.64 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.25 172.21 40.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 99.3 m -143.19 -163.76 1.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -1.107 . . . . 0.0 110.131 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.78 -170.73 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.023 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -39.86 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.009 -179.543 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.07 55.31 2.17 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.283 2.0 m-85 -98.12 118.37 34.59 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.486 -1.008 . . . . 0.0 109.243 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.26 123.98 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.32 -179.565 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.518 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.04 131.65 7.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.008 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 32.2 p -100.28 149.12 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.02 -28.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.508 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -7.31 38.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 84.35 43.97 6.77 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG3' ' C ' ' A' ' 17' ' ' GLY . 62.3 mtp85 -142.78 161.36 38.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -1.054 . . . . 0.0 110.808 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.2 m -89.87 126.09 35.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.473 -0.767 . . . . 0.0 109.925 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 12' ' ' MET . 15.0 ttpp -131.63 130.89 22.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.9 Cg_endo -73.59 132.96 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.695 1.366 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 22' ' ' THR . 9.3 p -73.25 90.47 1.62 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.295 0.569 . . . . 0.0 110.236 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.286 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.157 0.503 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -116.55 163.43 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.135 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -129.4 82.92 2.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.63 79.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.65 143.58 9.64 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -156.71 66.09 0.3 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.3 m -127.15 176.54 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -1.125 . . . . 0.0 110.483 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' CB ' ' CD1' ' A' ' 11' ' ' PHE . . . -90.07 -169.24 2.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 110.182 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.58 -95.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.349 -0.845 . . . . 0.0 110.764 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.79 54.41 3.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.684 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.7 m-85 -98.13 124.5 42.71 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.379 -1.071 . . . . 0.0 108.767 179.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.1 ttp -99.13 138.63 35.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 110.342 -179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.51 124.39 23.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 110.207 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.1 p -89.77 146.62 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.819 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.71 -28.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.692 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' THR . 80.6 m-20 -69.76 -13.33 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.81 40.66 4.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.9 mmt180 -134.91 155.66 50.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -1.175 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 76.8 m -94.59 125.98 39.58 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.601 -0.687 . . . . 0.0 110.126 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 129.0 23.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.684 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.54 135.53 24.32 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.657 1.346 . . . . 0.0 111.937 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.41 ' O ' ' OG1' ' A' ' 22' ' ' THR . 10.3 p -74.69 102.77 4.73 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.295 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.242 -179.965 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.347 0.594 . . . . 0.0 110.206 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' PHE . 67.2 t30 60.44 93.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER 45.29 -171.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.826 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' PHE . . . 42.73 44.42 3.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.299 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.31 64.54 2.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.93 25.08 67.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 87.0 m -125.65 -169.92 2.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -1.084 . . . . 0.0 110.18 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.592 ' HB3' ' CG ' ' A' ' 11' ' ' PHE . . . -93.61 -171.63 2.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.27 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -41.39 -97.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.4 -0.812 . . . . 0.0 111.035 -179.63 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -89.28 53.86 3.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.669 ' CE1' ' HB3' ' A' ' 21' ' ' PRO 0.275 1.9 m-85 -98.55 118.93 36.35 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.427 -1.043 . . . . 0.0 109.066 -179.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.88 122.85 42.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.016 . . . . 0.0 110.367 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.24 128.41 9.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 110.269 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.416 HG22 ' HD2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -89.7 143.88 26.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.834 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.87 -28.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.545 -0.722 . . . . 0.0 110.689 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -69.88 -18.92 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 110.123 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.93 43.87 2.01 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 20.8 mtp85 -141.05 162.57 35.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.222 -1.163 . . . . 0.0 110.761 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -94.14 119.66 33.28 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -128.3 132.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.669 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.38 134.7 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.852 1.449 . . . . 0.0 111.723 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 p -74.77 -47.91 28.38 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.27 0.557 . . . . 0.0 110.401 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.5 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.151 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -91.3 -169.71 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.24 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 111.017 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.05 55.03 4.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.151 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.49 120.13 38.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.452 -1.028 . . . . 0.0 108.907 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.71 128.41 44.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.413 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.42 122.09 10.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.9 p -89.94 147.93 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.56 -27.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' THR . 26.0 m-20 -70.12 -4.27 20.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 81.8 37.36 16.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.4 mtp-105 -133.17 163.14 29.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.729 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.2 m -95.96 121.28 37.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.563 -0.71 . . . . 0.0 110.024 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.9 mttm -127.91 131.71 23.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.002 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.75 124.73 9.95 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.746 1.393 . . . . 0.0 111.672 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 22' ' ' THR . 14.1 p . . . . . 0 N--CA 1.489 1.481 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.3 m . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.142 0.496 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.098 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -86.59 -170.21 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 111.145 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.09 54.58 2.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.098 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 2.1 m-85 -97.87 119.3 36.23 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.565 -0.962 . . . . 0.0 109.095 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -99.16 123.6 43.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.945 -1.097 . . . . 0.0 110.342 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -46.82 133.96 10.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.378 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.505 ' CG2' ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -100.9 151.28 21.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.8 -29.64 0.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.552 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -70.99 -3.72 21.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.87 40.24 10.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.2 mtp85 -134.67 162.0 33.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.429 -1.042 . . . . 0.0 110.679 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -94.59 129.59 41.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.42 -0.8 . . . . 0.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 2.0 tmmm? -134.29 131.11 20.45 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 109.934 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.3 Cg_endo -73.98 138.89 26.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.789 1.415 . . . . 0.0 111.638 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.0 p . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 121.203 0.525 . . . . 0.0 110.351 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.2 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.186 0.517 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.044 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.08 -170.54 2.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.221 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.85 -98.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.41 -0.806 . . . . 0.0 111.093 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.6 54.96 3.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.044 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.285 1.8 m-85 -98.29 117.62 33.1 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.596 -0.944 . . . . 0.0 109.318 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.3 128.67 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 110.117 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.2 mmt180 -51.62 121.63 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 110.283 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 18' ' ' ARG . 8.3 t -89.84 149.45 22.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.56 -27.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.655 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.53 -5.95 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.09 41.68 8.47 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 29.3 mmt180 -139.9 161.72 36.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -1.184 . . . . 0.0 110.688 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 77.7 m -89.93 116.78 28.24 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.482 -0.761 . . . . 0.0 109.718 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' MET . 59.9 tttt -122.7 130.28 24.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 110.35 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.5 Cg_endo -71.72 130.43 16.98 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.814 1.429 . . . . 0.0 111.634 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 22' ' ' THR . 28.0 p . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.586 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 95.7 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.285 0.564 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.161 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.86 -169.95 2.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.963 . . . . 0.0 110.322 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.41 -97.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.983 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.65 54.07 4.08 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.161 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.6 m-85 -98.02 121.19 39.65 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.431 -1.04 . . . . 0.0 108.966 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.3 ttm -99.04 128.38 45.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 130.29 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 15' ' ' ALA . 63.3 p -94.7 145.53 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.98 -29.01 0.3 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.795 . . . . 0.0 110.603 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.81 -13.73 62.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.09 42.61 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 23.3 mtt180 -138.65 156.64 47.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.805 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -92.7 123.46 36.0 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.1 ttpt -127.67 130.67 23.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.8 Cg_endo -72.71 130.17 15.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.684 1.36 . . . . 0.0 112.055 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 22' ' ' THR . 29.2 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 93.1 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.357 0.599 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.142 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.99 -168.48 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.4 -0.813 . . . . 0.0 110.758 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.35 56.58 2.04 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.142 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.6 m-85 -98.03 120.48 38.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.482 -1.011 . . . . 0.0 109.092 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.11 132.48 44.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 0.0 110.281 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.88 126.21 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 41.9 p -89.86 149.92 22.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.943 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -42.81 -30.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.633 -0.667 . . . . 0.0 110.802 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -14.76 62.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.075 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.03 3.43 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 33.5 mtp180 -137.04 154.92 50.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -1.174 . . . . 0.0 110.77 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.4 m -89.79 118.2 29.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.259 -0.901 . . . . 0.0 110.099 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 10.5 tttt -122.61 130.53 24.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.019 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.0 Cg_endo -71.06 130.34 17.6 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.647 1.341 . . . . 0.0 111.639 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 22' ' ' THR . 5.1 p . . . . . 0 C--N 1.303 -1.438 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.28 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.06 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.8 -172.49 3.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.491 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -42.2 -98.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.432 -0.793 . . . . 0.0 111.133 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.95 52.81 4.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.06 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.9 m-85 -98.41 118.27 34.71 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -1.022 . . . . 0.0 109.139 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.6 ttt -99.12 118.27 35.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.118 . . . . 0.0 110.123 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.5 tpp85 -43.48 127.87 4.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 110.303 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 30.6 p -92.0 146.13 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.46 -26.57 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -9.6 55.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.021 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.55 43.06 5.3 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.7 mtp-105 -142.13 159.74 41.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 0.0 110.756 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -91.23 121.25 32.82 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.508 -0.745 . . . . 0.0 109.93 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 0.4 OUTLIER -130.0 133.55 25.11 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 110.049 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.661 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.2 Cg_endo -73.69 138.63 26.78 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.805 1.424 . . . . 0.0 111.642 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 10' ' ' GLY . 5.5 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 83.9 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.225 0.536 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.116 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.01 -172.05 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.91 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 111.079 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.23 55.4 2.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.116 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.9 m-85 -98.26 120.83 39.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.494 -1.004 . . . . 0.0 108.811 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.3 tpp -99.22 121.23 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 110.31 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -50.27 128.47 19.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 p -89.78 145.99 24.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.856 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.05 -29.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.66 -13.95 62.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 96.53 47.13 2.39 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.5 mmt180 -141.19 154.11 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 81.1 m -91.67 123.53 35.13 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.622 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 10.8 mttt -131.51 131.54 22.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.7 Cg_endo -74.59 139.41 25.4 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.812 1.427 . . . . 0.0 111.797 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.7 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.239 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.1 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.158 0.504 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.084 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.59 -170.82 3.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 110.167 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.419 -0.801 . . . . 0.0 111.0 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.9 3.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.084 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.78 121.11 40.3 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.449 -1.03 . . . . 0.0 109.394 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.17 133.36 43.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 0.0 110.081 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -58.3 126.52 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.342 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 18' ' ' ARG . 1.2 p -90.22 150.38 22.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.87 -30.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -69.85 -9.54 55.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.054 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 89.32 42.33 5.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 8.1 mmm180 -135.36 157.59 46.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -1.108 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.62 117.52 29.81 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 109.95 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 12' ' ' MET . 26.1 mttt -124.71 132.09 24.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.657 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.74 132.57 20.42 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.764 1.402 . . . . 0.0 111.752 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 22' ' ' THR . 9.7 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.671 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 92.7 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.261 0.553 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.1 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.78 -171.67 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.266 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.0 -96.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.481 -0.762 . . . . 0.0 111.046 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.47 3.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.1 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.11 117.21 31.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.479 -1.013 . . . . 0.0 109.089 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' LYS . 2.6 tpt -98.99 123.63 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.983 -1.073 . . . . 0.0 110.115 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.57 128.58 8.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.455 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.8 147.35 23.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.99 -29.12 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -0.75 . . . . 0.0 110.615 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -13.45 62.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.9 41.79 3.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 6.3 mtt180 -139.16 160.0 40.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.135 -1.215 . . . . 0.0 110.712 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 73.9 m -89.2 120.12 30.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.236 -0.915 . . . . 0.0 110.002 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 12' ' ' MET . 66.7 tttt -126.76 130.66 23.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 110.235 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.48 138.53 29.92 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.64 1.337 . . . . 0.0 111.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 10' ' ' GLY . 7.4 p . . . . . 0 N--CA 1.488 1.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.617 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.0 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.246 0.546 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.103 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -88.42 -170.31 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.826 . . . . 0.0 111.033 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.48 55.45 2.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.8 m-85 -98.39 119.81 37.72 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.468 -1.019 . . . . 0.0 109.246 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -98.75 130.1 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.86 -1.15 . . . . 0.0 110.206 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.2 mmt180 -54.55 124.3 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 110.05 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.99 151.31 20.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.91 -27.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.54 -6.46 31.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.854 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.21 41.25 8.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 10.7 mtp180 -140.19 161.85 36.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -1.086 . . . . 0.0 110.847 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.29 127.32 36.68 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 18.1 ttpp -132.49 132.07 22.58 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.912 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.9 Cg_endo -74.04 139.63 27.27 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.698 1.367 . . . . 0.0 111.842 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.298 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 84.7 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.143 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.01 -168.91 1.99 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.31 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.41 -97.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 111.002 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' THR . . . -90.92 54.51 3.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.143 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 1.6 m-85 -97.87 119.33 36.28 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.522 -0.987 . . . . 0.0 109.066 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -98.95 136.51 38.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.935 -1.103 . . . . 0.0 110.407 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.05 127.61 33.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.62 151.56 21.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.12 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 110.872 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -69.81 -11.92 61.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 0.0 110.169 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.55 46.96 3.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 71.1 mtp85 -137.97 155.79 48.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.277 -1.131 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -89.74 121.14 31.62 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.5 tttp -127.09 131.37 23.82 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.938 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.92 138.59 28.78 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.667 1.351 . . . . 0.0 111.831 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.7 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.247 0.546 . . . . 0.0 110.253 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.214 0.531 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.083 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.76 -169.27 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.54 -98.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.417 -0.802 . . . . 0.0 111.096 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.39 56.06 2.39 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.286 2.1 m-85 -97.66 122.68 41.02 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.528 -0.984 . . . . 0.0 109.3 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.7 ttt -99.26 131.2 45.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.97 -1.081 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.68 126.81 28.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -93.9 144.57 25.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.33 -0.856 . . . . 0.0 109.922 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.9 -27.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 -6.96 35.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 87.16 48.55 4.3 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 3.0 mmm180 -147.88 160.9 42.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -1.12 . . . . 0.0 110.78 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.3 m -96.06 126.92 41.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.559 -0.713 . . . . 0.0 109.894 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 28.1 tttp -129.4 130.44 23.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -72.6 135.35 23.87 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.616 1.324 . . . . 0.0 111.892 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 10' ' ' GLY . 14.4 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.184 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 96.8 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.218 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.09 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -99.21 -171.54 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.19 -98.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 111.155 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -87.75 53.76 4.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.09 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.271 1.9 m-85 -98.14 118.99 35.99 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.459 -1.024 . . . . 0.0 109.049 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.5 ttp -99.16 114.17 26.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 110.292 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.16 127.36 4.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 110.096 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 20' ' ' LYS . 1.2 p -89.6 143.94 26.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.69 -27.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.699 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.75 -16.51 63.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.993 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 18' ' ' ARG . . . 99.2 40.14 3.33 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 mmt-85 -137.88 156.26 48.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -1.201 . . . . 0.0 110.777 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.97 118.27 30.22 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.539 -0.726 . . . . 0.0 110.103 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 14' ' ' THR . 1.1 mmtt -126.84 130.83 23.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.6 Cg_endo -72.92 135.88 24.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.816 1.429 . . . . 0.0 111.814 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.0 p . . . . . 0 N--CA 1.488 1.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.27 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.0 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.24 0.543 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.094 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -82.26 -169.73 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.63 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.525 -0.734 . . . . 0.0 110.893 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.54 56.35 1.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.094 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.9 m-85 -98.12 118.01 33.78 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.457 -1.025 . . . . 0.0 109.222 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -98.95 125.74 44.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 110.12 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.56 126.75 8.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.848 . . . . 0.0 110.592 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.3 m -90.28 144.11 26.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.11 -26.79 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.838 . . . . 0.0 110.346 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-20 -70.56 -9.62 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.29 47.03 3.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 7.2 mtt180 -147.54 160.13 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.684 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.07 123.87 34.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 3.7 tttp -130.23 133.62 25.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 109.868 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.4 Cg_endo -73.63 137.04 24.43 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.833 1.438 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 121.311 0.576 . . . . 0.0 110.411 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.4 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.174 0.511 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -87.5 -171.23 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.78 -97.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 111.056 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.12 54.2 4.24 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.267 1.8 m-85 -98.42 119.09 36.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.402 -1.058 . . . . 0.0 108.939 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -99.06 120.4 39.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 110.406 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.62 127.58 4.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 110.294 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -93.12 148.04 22.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.03 -27.49 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.327 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -8.21 47.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 86.69 38.36 8.17 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.3 mmm-85 -134.7 159.45 41.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -1.015 . . . . 0.0 110.605 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.6 m -90.71 122.51 33.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.423 -0.798 . . . . 0.0 109.793 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -129.56 131.0 23.31 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.092 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.5 Cg_endo -73.45 134.35 20.51 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.787 1.414 . . . . 0.0 111.603 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 22' ' ' THR . 8.8 p . . . . . 0 N--CA 1.488 1.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.469 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.0 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.177 0.513 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.981 ' HB3' ' CG ' ' A' ' 11' ' ' PHE . . . -71.12 -174.66 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.26 -99.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.454 -0.779 . . . . 0.0 111.334 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.86 54.39 4.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.981 ' CG ' ' HB3' ' A' ' 8' ' ' ALA 0.278 1.9 m-85 -98.64 118.65 35.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.513 -0.992 . . . . 0.0 109.489 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.1 ttt -99.28 125.89 45.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 110.244 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.79 133.44 4.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 110.312 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -95.08 149.59 21.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.738 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.13 -35.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 17.1 p30 -69.41 -8.31 45.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.143 -0.973 . . . . 0.0 110.406 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.53 46.31 4.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -138.11 162.92 32.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -1.182 . . . . 0.0 110.504 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -91.68 119.98 32.03 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.288 -0.882 . . . . 0.0 109.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -129.06 131.49 23.75 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 110.068 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.666 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.49 134.6 22.75 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.666 1.351 . . . . 0.0 111.795 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 22' ' ' THR . 7.6 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.425 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 89.8 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.08 0.467 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.169 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.05 -170.1 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.983 . . . . 0.0 110.346 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.73 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.469 -0.769 . . . . 0.0 111.155 -179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.56 53.97 4.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.169 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.269 1.8 m-85 -98.03 116.7 30.77 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 108.942 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -99.01 126.39 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 110.435 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -47.55 125.46 8.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.432 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.8 147.24 23.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.64 -29.41 0.49 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.506 -0.746 . . . . 0.0 110.685 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.474 ' OD1' ' HB ' ' A' ' 14' ' ' THR . 25.6 p30 -70.1 -9.54 55.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.15 -0.969 . . . . 0.0 110.04 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 90.08 47.76 3.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.1 mtp85 -146.04 164.0 33.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.182 -1.187 . . . . 0.0 110.624 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.34 118.5 29.88 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.456 -0.777 . . . . 0.0 110.264 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -124.59 127.89 25.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.981 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.0 Cg_endo -72.82 135.42 23.52 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.831 1.437 . . . . 0.0 111.967 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.9 p . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.197 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 91.2 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.224 0.535 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.104 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -79.09 -170.53 2.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.11 -98.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.521 -0.737 . . . . 0.0 111.231 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.62 55.34 3.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.104 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.277 1.7 m-85 -98.24 118.81 35.72 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.589 -0.948 . . . . 0.0 109.171 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.5 tpp -99.48 126.76 45.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.989 -1.069 . . . . 0.0 110.341 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -51.58 120.59 5.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 110.065 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -89.69 146.89 24.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.05 -25.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.499 -0.751 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -69.27 -7.69 39.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 109.801 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 85.04 47.18 5.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -149.58 161.01 43.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -1.129 . . . . 0.0 110.762 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 77.5 m -89.96 118.07 29.25 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.52 -0.738 . . . . 0.0 109.902 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 14.8 tmtt? -123.46 130.47 24.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.114 -0.991 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.99 138.32 30.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.803 1.423 . . . . 0.0 111.809 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.2 p . . . . . 0 C--N 1.302 -1.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.321 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 68.9 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.241 0.543 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.7 -171.99 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.108 -0.995 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.74 -97.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.433 -0.792 . . . . 0.0 111.111 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.43 55.43 2.76 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.018 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.28 2.0 m-85 -98.73 119.88 38.22 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.498 -1.001 . . . . 0.0 109.408 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -98.99 121.88 41.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.997 -1.065 . . . . 0.0 110.255 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.1 mmt180 -46.01 127.61 8.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.564 HG21 ' HD3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -91.98 146.27 23.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.895 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.73 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.404 -0.81 . . . . 0.0 110.522 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 8.4 m-20 -69.86 -9.93 56.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.97 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.33 5.3 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.5 mtp180 -142.57 160.94 39.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -1.227 . . . . 0.0 110.697 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.75 124.39 35.85 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.428 -0.795 . . . . 0.0 110.466 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' HG21 ' A' ' 14' ' ' THR . 2.4 tttp -132.01 134.28 24.99 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.704 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.03 123.27 8.75 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.85 1.447 . . . . 0.0 111.436 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 22' ' ' THR . 15.7 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 74.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.41 0.624 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.167 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -89.6 -168.19 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.534 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.59 -0.694 . . . . 0.0 111.016 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.5 55.42 3.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.167 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.8 m-85 -98.01 119.17 36.16 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.479 -1.012 . . . . 0.0 109.014 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.2 ttm -99.14 131.23 45.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 110.356 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -52.5 125.14 15.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 110.302 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.89 146.35 24.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.12 -28.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 -2.73 21.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 18' ' ' ARG . . . 83.4 48.67 5.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.4 mtt85 -144.85 162.65 36.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -1.193 . . . . 0.0 110.721 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -95.35 120.71 36.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.426 -0.797 . . . . 0.0 109.831 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.5 tttp -126.61 131.56 23.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.102 -0.999 . . . . 0.0 110.128 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.2 Cg_endo -73.07 133.53 19.84 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.772 1.406 . . . . 0.0 111.492 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.1 p . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.191 0.52 . . . . 0.0 110.541 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.9 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.297 0.57 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -71.32 -170.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.28 -94.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.37 -0.831 . . . . 0.0 110.714 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.48 54.18 3.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.23 119.91 37.73 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.447 -1.031 . . . . 0.0 108.743 179.838 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -99.11 121.42 40.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 0.0 110.711 -179.056 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.73 122.73 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.248 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 147.67 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.882 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.25 -27.71 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.6 -6.42 31.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.8 42.84 6.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.8 mmt85 -142.4 162.43 35.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.155 . . . . 0.0 110.411 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.6 m -95.25 119.47 33.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -122.64 131.26 24.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.165 -0.959 . . . . 0.0 110.157 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.685 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.1 Cg_endo -71.74 132.51 20.32 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.808 1.425 . . . . 0.0 111.776 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 10' ' ' GLY . 15.3 p . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.337 0.589 . . . . 0.0 110.273 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.196 0.522 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.069 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -84.47 -169.4 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.383 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.452 -0.78 . . . . 0.0 111.061 -179.571 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.38 55.49 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.069 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.278 2.3 m-85 -97.74 120.49 38.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.534 -0.98 . . . . 0.0 109.144 -179.736 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.4 ttp -99.14 123.47 43.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.003 -1.061 . . . . 0.0 110.432 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -48.11 130.27 15.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 110.3 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -99.34 143.92 29.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.71 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.558 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 11.5 t0 -69.74 -10.85 59.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 110.028 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 90.34 43.4 4.95 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 17' ' ' GLY . 14.4 mtp180 -142.56 158.22 43.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -1.099 . . . . 0.0 110.66 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -93.49 119.17 32.24 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.467 -0.77 . . . . 0.0 109.734 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 ttmt -123.15 130.83 24.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.684 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.65 139.79 31.56 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.856 1.451 . . . . 0.0 111.987 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 p . . . . . 0 C--N 1.303 -1.449 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 99.3 m . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.164 0.507 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.78 -170.73 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.023 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.86 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.009 -179.543 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.07 55.31 2.17 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 2.0 m-85 -98.12 118.37 34.59 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.486 -1.008 . . . . 0.0 109.243 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.26 123.98 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.32 -179.565 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.518 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.04 131.65 7.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.008 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 20' ' ' LYS . 32.2 p -100.28 149.12 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.02 -28.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.508 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -7.31 38.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 84.35 43.97 6.77 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 62.3 mtp85 -142.78 161.36 38.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -1.054 . . . . 0.0 110.808 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.2 m -89.87 126.09 35.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.473 -0.767 . . . . 0.0 109.925 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.0 ttpp -131.63 130.89 22.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.9 Cg_endo -73.59 132.96 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.695 1.366 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.3 p . . . . . 0 C--N 1.302 -1.478 0 CA-C-O 121.295 0.569 . . . . 0.0 110.236 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.3 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.168 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.07 -169.24 2.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 110.182 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.58 -95.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.349 -0.845 . . . . 0.0 110.764 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.79 54.41 3.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.168 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.13 124.5 42.71 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.379 -1.071 . . . . 0.0 108.767 179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.1 ttp -99.13 138.63 35.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 110.342 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.51 124.39 23.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 110.207 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.1 p -89.77 146.62 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.819 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.71 -28.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.692 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' THR . 80.6 m-20 -69.76 -13.33 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.81 40.66 4.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.9 mmt180 -134.91 155.66 50.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -1.175 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.8 m -94.59 125.98 39.58 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.601 -0.687 . . . . 0.0 110.126 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.95 129.0 23.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.54 135.53 24.32 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.657 1.346 . . . . 0.0 111.937 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.295 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 87.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.079 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.61 -171.63 2.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.27 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.39 -97.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.4 -0.812 . . . . 0.0 111.035 -179.63 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -89.28 53.86 3.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.079 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.9 m-85 -98.55 118.93 36.35 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.427 -1.043 . . . . 0.0 109.066 -179.951 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.88 122.85 42.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.016 . . . . 0.0 110.367 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.24 128.41 9.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 110.269 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.7 143.88 26.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.834 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.87 -28.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.545 -0.722 . . . . 0.0 110.689 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -69.88 -18.92 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 110.123 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.93 43.87 2.01 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 20.8 mtp85 -141.05 162.57 35.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.222 -1.163 . . . . 0.0 110.761 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -94.14 119.66 33.28 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -128.3 132.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.38 134.7 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.852 1.449 . . . . 0.0 111.723 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 22' ' ' THR . 7.5 p . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 121.27 0.557 . . . . 0.0 110.401 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.511 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 2.5 pp20? . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.244 0.545 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 1' ' ' GLU . 0.5 OUTLIER -179.45 106.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -162.9 117.11 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.7 14.86 4.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.219 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.62 -149.82 18.69 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.11 61.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.5 m -106.25 176.89 5.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 110.186 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.151 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -91.3 -169.71 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.24 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 111.017 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.05 55.03 4.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.151 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.49 120.13 38.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.452 -1.028 . . . . 0.0 108.907 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.71 128.41 44.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.413 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.42 122.09 10.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.9 p -89.94 147.93 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.56 -27.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' THR . 26.0 m-20 -70.12 -4.27 20.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 81.8 37.36 16.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.4 mtp-105 -133.17 163.14 29.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.729 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.2 m -95.96 121.28 37.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.563 -0.71 . . . . 0.0 110.024 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.9 mttm -127.91 131.71 23.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.002 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.75 124.73 9.95 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.746 1.393 . . . . 0.0 111.672 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 22' ' ' THR . 14.1 p -67.1 -19.39 65.63 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' ASN . 9.2 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.214 0.531 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' GLU . 65.2 t30 55.28 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.844 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 3.2 t80 64.99 64.46 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 3' ' ' PHE . . . 179.82 61.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.51 115.77 7.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 173.07 156.46 12.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.3 m -142.18 -176.14 4.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -1.165 . . . . 0.0 110.388 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.098 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -86.59 -170.21 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 111.145 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.09 54.58 2.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.098 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 2.1 m-85 -97.87 119.3 36.23 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.565 -0.962 . . . . 0.0 109.095 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -99.16 123.6 43.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.945 -1.097 . . . . 0.0 110.342 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -46.82 133.96 10.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.378 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.505 ' CG2' ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -100.9 151.28 21.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.8 -29.64 0.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.552 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -70.99 -3.72 21.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.87 40.24 10.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.2 mtp85 -134.67 162.0 33.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.429 -1.042 . . . . 0.0 110.679 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 76.6 m -94.59 129.59 41.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.42 -0.8 . . . . 0.0 110.018 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 2.0 tmmm? -134.29 131.11 20.45 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 109.934 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.3 Cg_endo -73.98 138.89 26.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.789 1.415 . . . . 0.0 111.638 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.0 p -79.54 -1.12 36.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.203 0.525 . . . . 0.0 110.351 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.358 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 1.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.257 0.551 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -126.45 164.48 21.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -89.54 171.77 9.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.073 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.07 149.82 40.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.193 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.16 -130.64 6.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -79.25 90.75 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.2 m -141.87 -173.55 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.181 . . . . 0.0 110.161 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.044 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.08 -170.54 2.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.221 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.85 -98.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.41 -0.806 . . . . 0.0 111.093 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.6 54.96 3.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.044 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.285 1.8 m-85 -98.29 117.62 33.1 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.596 -0.944 . . . . 0.0 109.318 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.3 128.67 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 110.117 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.2 mmt180 -51.62 121.63 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 110.283 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 18' ' ' ARG . 8.3 t -89.84 149.45 22.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.56 -27.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.655 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.53 -5.95 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.09 41.68 8.47 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 29.3 mmt180 -139.9 161.72 36.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -1.184 . . . . 0.0 110.688 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 77.7 m -89.93 116.78 28.24 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.482 -0.761 . . . . 0.0 109.718 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' MET . 59.9 tttt -122.7 130.28 24.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 110.35 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.5 Cg_endo -71.72 130.43 16.98 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.814 1.429 . . . . 0.0 111.634 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 23' ' ' PHE . 28.0 p -62.5 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.586 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 32.1 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.224 0.535 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 49.2 73.35 0.24 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.18 104.29 4.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.368 -0.832 . . . . 0.0 110.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.21 140.51 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.093 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.87 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.47 77.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 95.7 m -120.78 169.95 9.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -1.107 . . . . 0.0 110.051 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.161 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.86 -169.95 2.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.963 . . . . 0.0 110.322 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.41 -97.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.983 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.65 54.07 4.08 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.161 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.6 m-85 -98.02 121.19 39.65 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.431 -1.04 . . . . 0.0 108.966 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.3 ttm -99.04 128.38 45.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 130.29 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 15' ' ' ALA . 63.3 p -94.7 145.53 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.98 -29.01 0.3 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.795 . . . . 0.0 110.603 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.81 -13.73 62.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.09 42.61 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 23.3 mtt180 -138.65 156.64 47.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.805 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -92.7 123.46 36.0 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.1 ttpt -127.67 130.67 23.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.8 Cg_endo -72.71 130.17 15.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.684 1.36 . . . . 0.0 112.055 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 23' ' ' PHE . 29.2 p -60.52 -92.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' N ' ' OG1' ' A' ' 22' ' ' THR . 18.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 110.226 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 32.0 mm-40 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.222 0.534 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.2 t30 63.86 142.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 140.37 57.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.63 51.91 1.43 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.859 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.81 157.31 45.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -163.03 89.62 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 93.1 m -123.42 164.54 18.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.157 . . . . 0.0 110.673 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.142 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.99 -168.48 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.4 -0.813 . . . . 0.0 110.758 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.35 56.58 2.04 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.142 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.6 m-85 -98.03 120.48 38.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.482 -1.011 . . . . 0.0 109.092 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.11 132.48 44.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 0.0 110.281 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.88 126.21 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 41.9 p -89.86 149.92 22.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.943 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -42.81 -30.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.633 -0.667 . . . . 0.0 110.802 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -14.76 62.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.075 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.03 3.43 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 33.5 mtp180 -137.04 154.92 50.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -1.174 . . . . 0.0 110.77 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.4 m -89.79 118.2 29.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.259 -0.901 . . . . 0.0 110.099 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 10.5 tttt -122.61 130.53 24.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.019 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.0 Cg_endo -71.06 130.34 17.6 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.647 1.341 . . . . 0.0 111.639 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 22' ' ' THR . 5.1 p -78.47 -15.92 58.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.28 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.224 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 3' ' ' PHE . 2.2 mp0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.65 67.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -147.75 97.05 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.236 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' PHE . . . 48.87 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.965 . . . . 0.0 110.217 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.79 -147.1 4.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 99.03 134.57 8.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m -139.53 -179.87 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -1.168 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.06 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.8 -172.49 3.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.491 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -42.2 -98.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.432 -0.793 . . . . 0.0 111.133 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.95 52.81 4.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.06 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.9 m-85 -98.41 118.27 34.71 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -1.022 . . . . 0.0 109.139 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.6 ttt -99.12 118.27 35.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.118 . . . . 0.0 110.123 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.5 tpp85 -43.48 127.87 4.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 110.303 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 30.6 p -92.0 146.13 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.46 -26.57 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -9.6 55.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.021 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.55 43.06 5.3 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.7 mtp-105 -142.13 159.74 41.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 0.0 110.756 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 80.8 m -91.23 121.25 32.82 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.508 -0.745 . . . . 0.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 0.4 OUTLIER -130.0 133.55 25.11 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 110.049 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.661 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.2 Cg_endo -73.69 138.63 26.78 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.805 1.424 . . . . 0.0 111.642 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 10' ' ' GLY . 5.5 p -83.19 42.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.232 0.539 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -113.98 69.2 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.668 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 0.3 OUTLIER 59.66 169.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.359 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 3' ' ' PHE . . . 65.81 155.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.235 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.02 78.61 1.38 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.95 168.23 39.63 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 83.9 m -146.08 -159.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -1.121 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.116 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.01 -172.05 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.91 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 111.079 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.23 55.4 2.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.116 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.9 m-85 -98.26 120.83 39.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.494 -1.004 . . . . 0.0 108.811 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.3 tpp -99.22 121.23 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 110.31 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -50.27 128.47 19.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 p -89.78 145.99 24.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.856 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.05 -29.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.66 -13.95 62.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 96.53 47.13 2.39 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.5 mmt180 -141.19 154.11 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 81.1 m -91.67 123.53 35.13 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.622 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 10.8 mttt -131.51 131.54 22.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.7 Cg_endo -74.59 139.41 25.4 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.812 1.427 . . . . 0.0 111.797 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.7 p -80.8 -35.52 32.91 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.239 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.156 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 2.3 mt-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 2.5 t-20 65.04 135.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.05 120.87 3.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.23 -19.32 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 13' ' ' ARG . . . -57.35 -35.34 71.02 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -49.0 160.94 0.68 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.1 m -133.11 177.1 7.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.011 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.084 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.59 -170.82 3.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 110.167 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.419 -0.801 . . . . 0.0 111.0 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.9 3.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.084 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.78 121.11 40.3 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.449 -1.03 . . . . 0.0 109.394 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.17 133.36 43.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 0.0 110.081 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -58.3 126.52 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.342 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 18' ' ' ARG . 1.2 p -90.22 150.38 22.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.87 -30.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -69.85 -9.54 55.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.054 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 89.32 42.33 5.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 8.1 mmm180 -135.36 157.59 46.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -1.108 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 78.2 m -91.62 117.52 29.81 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 109.95 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 12' ' ' MET . 26.1 mttt -124.71 132.09 24.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.657 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.74 132.57 20.42 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.764 1.402 . . . . 0.0 111.752 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 22' ' ' THR . 9.7 p -71.78 -27.14 62.75 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.671 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 110.246 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.416 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 3.8 mm-40 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 1.5 m-20 -120.94 138.53 54.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -160.38 61.25 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 0.0 110.091 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.95 135.62 52.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.83 157.6 17.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -129.77 63.17 0.63 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 92.7 m -145.76 -168.8 3.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.1 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.78 -171.67 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.266 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.0 -96.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.481 -0.762 . . . . 0.0 111.046 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.47 3.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.1 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.11 117.21 31.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.479 -1.013 . . . . 0.0 109.089 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' LYS . 2.6 tpt -98.99 123.63 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.983 -1.073 . . . . 0.0 110.115 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.57 128.58 8.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.455 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.8 147.35 23.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.99 -29.12 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -0.75 . . . . 0.0 110.615 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -13.45 62.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.9 41.79 3.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 6.3 mtt180 -139.16 160.0 40.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.135 -1.215 . . . . 0.0 110.712 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 73.9 m -89.2 120.12 30.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.236 -0.915 . . . . 0.0 110.002 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 12' ' ' MET . 66.7 tttt -126.76 130.66 23.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 110.235 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.48 138.53 29.92 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.64 1.337 . . . . 0.0 111.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 10' ' ' GLY . 7.4 p -76.63 -3.7 39.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.617 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.3 t80 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.234 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 56.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.23 0.538 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.0 OUTLIER 174.91 134.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.316 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -114.7 145.39 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.212 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 3' ' ' PHE . . . 175.99 46.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.45 -111.39 0.05 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.04 68.01 3.06 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.0 m -134.13 -175.27 3.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.385 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.103 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -88.42 -170.31 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.826 . . . . 0.0 111.033 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.48 55.45 2.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.8 m-85 -98.39 119.81 37.72 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.468 -1.019 . . . . 0.0 109.246 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -98.75 130.1 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.86 -1.15 . . . . 0.0 110.206 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.2 mmt180 -54.55 124.3 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 110.05 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.99 151.31 20.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.91 -27.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.54 -6.46 31.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.854 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.21 41.25 8.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 10.7 mtp180 -140.19 161.85 36.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -1.086 . . . . 0.0 110.847 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.29 127.32 36.68 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 18.1 ttpp -132.49 132.07 22.58 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.912 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.9 Cg_endo -74.04 139.63 27.27 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.698 1.367 . . . . 0.0 111.842 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p -78.73 65.75 4.05 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.298 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.126 179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.207 0.527 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' PHE . 31.2 t-20 -130.74 93.2 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ASN . 2.0 t80 43.05 70.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.5 -163.19 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -117.23 5.71 17.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 146.6 18.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 84.7 m -111.96 170.17 8.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.352 -1.087 . . . . 0.0 110.139 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.143 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.01 -168.91 1.99 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.31 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.41 -97.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 111.002 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' THR . . . -90.92 54.51 3.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.143 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 1.6 m-85 -97.87 119.33 36.28 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.522 -0.987 . . . . 0.0 109.066 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -98.95 136.51 38.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.935 -1.103 . . . . 0.0 110.407 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.05 127.61 33.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.62 151.56 21.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.12 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 110.872 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -69.81 -11.92 61.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 0.0 110.169 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.55 46.96 3.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 71.1 mtp85 -137.97 155.79 48.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.277 -1.131 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -89.74 121.14 31.62 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.5 tttp -127.09 131.37 23.82 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.938 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.92 138.59 28.78 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.667 1.351 . . . . 0.0 111.831 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.7 p -72.02 -30.35 65.12 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.247 0.546 . . . . 0.0 110.253 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.201 0.524 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' PHE . 7.3 t-20 -125.55 75.95 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ASN . 11.2 m-85 51.63 177.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.64 -23.84 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.059 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.25 166.07 40.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.45 157.27 22.71 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.5 m -124.77 173.03 8.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.015 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.083 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.76 -169.27 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.54 -98.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.417 -0.802 . . . . 0.0 111.096 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.39 56.06 2.39 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.286 2.1 m-85 -97.66 122.68 41.02 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.528 -0.984 . . . . 0.0 109.3 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.7 ttt -99.26 131.2 45.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.97 -1.081 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.68 126.81 28.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -93.9 144.57 25.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.33 -0.856 . . . . 0.0 109.922 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.9 -27.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 -6.96 35.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 87.16 48.55 4.3 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 3.0 mmm180 -147.88 160.9 42.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -1.12 . . . . 0.0 110.78 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.3 m -96.06 126.92 41.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.559 -0.713 . . . . 0.0 109.894 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 28.1 tttp -129.4 130.44 23.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -72.6 135.35 23.87 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.616 1.324 . . . . 0.0 111.892 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 10' ' ' GLY . 14.4 p -70.49 -19.38 62.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.184 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.19 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.239 0.542 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -79.31 57.84 2.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.272 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 59.17 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.69 143.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.272 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.88 90.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -164.71 155.32 26.64 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 96.8 m -139.76 -166.99 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.194 . . . . 0.0 110.294 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.09 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -99.21 -171.54 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.19 -98.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 111.155 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -87.75 53.76 4.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.09 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.271 1.9 m-85 -98.14 118.99 35.99 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.459 -1.024 . . . . 0.0 109.049 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.5 ttp -99.16 114.17 26.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 110.292 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.16 127.36 4.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 110.096 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 20' ' ' LYS . 1.2 p -89.6 143.94 26.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.69 -27.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.699 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.75 -16.51 63.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.993 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 18' ' ' ARG . . . 99.2 40.14 3.33 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 mmt-85 -137.88 156.26 48.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -1.201 . . . . 0.0 110.777 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 66.0 m -90.97 118.27 30.22 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.539 -0.726 . . . . 0.0 110.103 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 14' ' ' THR . 1.1 mmtt -126.84 130.83 23.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.6 Cg_endo -72.92 135.88 24.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.816 1.429 . . . . 0.0 111.814 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.0 p -72.2 56.16 0.33 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.27 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 t80 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.254 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.232 0.539 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -154.64 172.18 18.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.947 . . . . 0.0 110.369 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -50.77 168.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.33 -0.856 . . . . 0.0 110.389 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.36 68.15 1.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.119 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.79 -24.72 9.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.08 83.92 0.47 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.0 m -126.3 176.91 6.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.094 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -82.26 -169.73 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.63 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.525 -0.734 . . . . 0.0 110.893 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.54 56.35 1.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.094 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.9 m-85 -98.12 118.01 33.78 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.457 -1.025 . . . . 0.0 109.222 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -98.95 125.74 44.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 110.12 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.56 126.75 8.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.848 . . . . 0.0 110.592 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.3 m -90.28 144.11 26.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.11 -26.79 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.838 . . . . 0.0 110.346 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-20 -70.56 -9.62 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.29 47.03 3.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 7.2 mtt180 -147.54 160.13 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.684 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.07 123.87 34.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 3.7 tttp -130.23 133.62 25.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 109.868 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.4 Cg_endo -73.63 137.04 24.43 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.833 1.438 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p -78.01 -31.52 50.61 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.311 0.576 . . . . 0.0 110.411 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.31 0.576 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 2' ' ' ASN . 13.2 p30 -123.19 -176.64 3.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -106.62 98.65 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.06 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.34 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.366 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.98 -144.39 4.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.73 41.24 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.4 m -120.74 178.92 4.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -1.125 . . . . 0.0 110.222 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -87.5 -171.23 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.78 -97.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 111.056 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.12 54.2 4.24 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.267 1.8 m-85 -98.42 119.09 36.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.402 -1.058 . . . . 0.0 108.939 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -99.06 120.4 39.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 110.406 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.62 127.58 4.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 110.294 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -93.12 148.04 22.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.03 -27.49 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.327 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -8.21 47.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 86.69 38.36 8.17 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.3 mmm-85 -134.7 159.45 41.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -1.015 . . . . 0.0 110.605 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.6 m -90.71 122.51 33.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.423 -0.798 . . . . 0.0 109.793 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -129.56 131.0 23.31 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.092 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.5 Cg_endo -73.45 134.35 20.51 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.787 1.414 . . . . 0.0 111.603 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 22' ' ' THR . 8.8 p -74.18 -25.39 59.68 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.469 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' OXT' ' CG ' ' A' ' 23' ' ' PHE . 12.1 t80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.182 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.213 0.53 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -124.32 74.8 1.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -64.58 159.12 22.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.16 119.38 10.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.04 -117.3 4.37 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' A' ' 7' ' ' CYS . . . 105.5 169.01 23.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.0 m -150.39 -174.56 4.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -1.124 . . . . 0.0 110.133 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.981 ' HB3' ' CG ' ' A' ' 11' ' ' PHE . . . -71.12 -174.66 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.26 -99.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.454 -0.779 . . . . 0.0 111.334 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.86 54.39 4.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.981 ' CG ' ' HB3' ' A' ' 8' ' ' ALA 0.278 1.9 m-85 -98.64 118.65 35.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.513 -0.992 . . . . 0.0 109.489 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.1 ttt -99.28 125.89 45.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 110.244 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.79 133.44 4.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 110.312 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -95.08 149.59 21.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.738 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.13 -35.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 17.1 p30 -69.41 -8.31 45.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.143 -0.973 . . . . 0.0 110.406 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.53 46.31 4.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -138.11 162.92 32.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -1.182 . . . . 0.0 110.504 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -91.68 119.98 32.03 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.288 -0.882 . . . . 0.0 109.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -129.06 131.49 23.75 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 110.068 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.666 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.49 134.6 22.75 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.666 1.351 . . . . 0.0 111.795 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 22' ' ' THR . 7.6 p -74.7 78.09 2.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.425 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.302 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.208 0.528 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.53 147.52 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.253 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -144.92 103.96 3.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.22 155.43 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.21 133.56 7.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 126.46 143.83 5.97 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 89.8 m -131.0 179.75 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -1.165 . . . . 0.0 110.091 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.169 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.05 -170.1 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.983 . . . . 0.0 110.346 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.73 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.469 -0.769 . . . . 0.0 111.155 -179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.56 53.97 4.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.169 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.269 1.8 m-85 -98.03 116.7 30.77 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 108.942 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -99.01 126.39 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 110.435 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -47.55 125.46 8.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.432 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.8 147.24 23.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.64 -29.41 0.49 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.506 -0.746 . . . . 0.0 110.685 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.474 ' OD1' ' HB ' ' A' ' 14' ' ' THR . 25.6 p30 -70.1 -9.54 55.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.15 -0.969 . . . . 0.0 110.04 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 90.08 47.76 3.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.1 mtp85 -146.04 164.0 33.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.182 -1.187 . . . . 0.0 110.624 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 64.6 m -90.34 118.5 29.88 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.456 -0.777 . . . . 0.0 110.264 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -124.59 127.89 25.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.981 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.0 Cg_endo -72.82 135.42 23.52 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.831 1.437 . . . . 0.0 111.967 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.9 p -72.3 -14.42 61.75 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.197 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.2 179.95 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.177 0.513 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' A' ' 2' ' ' ASN . 1.7 p-10 -153.29 74.35 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -87.87 161.31 17.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.918 . . . . 0.0 110.171 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.76 105.54 6.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.47 -63.4 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -178.05 52.2 0.1 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 91.2 m -133.18 171.72 13.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -1.169 . . . . 0.0 110.235 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.104 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -79.09 -170.53 2.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.11 -98.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.521 -0.737 . . . . 0.0 111.231 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.62 55.34 3.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.104 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.277 1.7 m-85 -98.24 118.81 35.72 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.589 -0.948 . . . . 0.0 109.171 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.5 tpp -99.48 126.76 45.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.989 -1.069 . . . . 0.0 110.341 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -51.58 120.59 5.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 110.065 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -89.69 146.89 24.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.05 -25.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.499 -0.751 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -69.27 -7.69 39.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 109.801 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 85.04 47.18 5.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -149.58 161.01 43.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -1.129 . . . . 0.0 110.762 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 77.5 m -89.96 118.07 29.25 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.52 -0.738 . . . . 0.0 109.902 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 14.8 tmtt? -123.46 130.47 24.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.114 -0.991 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.99 138.32 30.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.803 1.423 . . . . 0.0 111.809 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.2 p -69.78 -25.37 63.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.321 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.199 179.875 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.289 0.566 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -156.22 113.18 3.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.96 125.7 38.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.195 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.06 -92.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.361 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.9 -128.17 1.22 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 100.77 77.07 1.25 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 68.9 m -145.32 -178.18 5.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -1.127 . . . . 0.0 110.033 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.7 -171.99 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.108 -0.995 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.74 -97.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.433 -0.792 . . . . 0.0 111.111 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.43 55.43 2.76 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.018 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.28 2.0 m-85 -98.73 119.88 38.22 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.498 -1.001 . . . . 0.0 109.408 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -98.99 121.88 41.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.997 -1.065 . . . . 0.0 110.255 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.1 mmt180 -46.01 127.61 8.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.564 HG21 ' HD3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -91.98 146.27 23.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.895 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.73 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.404 -0.81 . . . . 0.0 110.522 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 8.4 m-20 -69.86 -9.93 56.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.97 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.33 5.3 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.5 mtp180 -142.57 160.94 39.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -1.227 . . . . 0.0 110.697 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 80.3 m -91.75 124.39 35.85 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.428 -0.795 . . . . 0.0 110.466 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' HG21 ' A' ' 14' ' ' THR . 2.4 tttp -132.01 134.28 24.99 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.704 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.03 123.27 8.75 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.85 1.447 . . . . 0.0 111.436 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 15.7 p -67.43 -24.57 65.65 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 22' ' ' THR . 10.4 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.217 0.532 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 55.02 95.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.115 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.66 125.92 30.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.85 178.59 8.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.133 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.47 72.04 1.27 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -112.02 159.5 13.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 74.6 m -122.48 171.94 8.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.183 . . . . 0.0 110.446 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.167 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -89.6 -168.19 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.534 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.59 -0.694 . . . . 0.0 111.016 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.5 55.42 3.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.167 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.8 m-85 -98.01 119.17 36.16 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.479 -1.012 . . . . 0.0 109.014 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.2 ttm -99.14 131.23 45.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 110.356 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -52.5 125.14 15.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 110.302 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.89 146.35 24.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.12 -28.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 -2.73 21.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 18' ' ' ARG . . . 83.4 48.67 5.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.4 mtt85 -144.85 162.65 36.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -1.193 . . . . 0.0 110.721 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 82.1 m -95.35 120.71 36.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.426 -0.797 . . . . 0.0 109.831 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.5 tttp -126.61 131.56 23.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.102 -0.999 . . . . 0.0 110.128 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.2 Cg_endo -73.07 133.53 19.84 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.772 1.406 . . . . 0.0 111.492 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.1 p -66.44 -34.9 78.98 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.191 0.52 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.256 179.961 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.296 0.569 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.24 171.09 14.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -107.15 66.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.8 169.06 4.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.321 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.41 -138.92 4.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 171.38 110.47 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.9 m -127.16 161.74 27.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -71.32 -170.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.28 -94.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.37 -0.831 . . . . 0.0 110.714 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.48 54.18 3.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.23 119.91 37.73 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.447 -1.031 . . . . 0.0 108.743 179.838 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -99.11 121.42 40.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 0.0 110.711 -179.056 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.73 122.73 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.248 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 147.67 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.882 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.25 -27.71 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.6 -6.42 31.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.8 42.84 6.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.8 mmt85 -142.4 162.43 35.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.155 . . . . 0.0 110.411 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 71.6 m -95.25 119.47 33.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -122.64 131.26 24.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.165 -0.959 . . . . 0.0 110.157 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.685 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.1 Cg_endo -71.74 132.51 20.32 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.808 1.425 . . . . 0.0 111.776 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 10' ' ' GLY . 15.3 p -67.93 91.54 0.34 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.337 0.589 . . . . 0.0 110.273 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.237 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.228 0.537 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -176.11 4.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.195 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -162.28 107.76 1.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.128 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.83 68.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 110.151 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 3' ' ' PHE . . . 79.08 -115.12 4.04 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.53 39.9 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.0 m -138.24 -179.26 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.059 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.069 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -84.47 -169.4 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.383 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.452 -0.78 . . . . 0.0 111.061 -179.571 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.38 55.49 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.069 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.278 2.3 m-85 -97.74 120.49 38.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.534 -0.98 . . . . 0.0 109.144 -179.736 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.4 ttp -99.14 123.47 43.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.003 -1.061 . . . . 0.0 110.432 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -48.11 130.27 15.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 110.3 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -99.34 143.92 29.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.71 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.558 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 16' ' ' ASP . 11.5 t0 -69.74 -10.85 59.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 110.028 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 90.34 43.4 4.95 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 17' ' ' GLY . 14.4 mtp180 -142.56 158.22 43.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -1.099 . . . . 0.0 110.66 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -93.49 119.17 32.24 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.467 -0.77 . . . . 0.0 109.734 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 ttmt -123.15 130.83 24.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.684 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.65 139.79 31.56 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.856 1.451 . . . . 0.0 111.987 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 p -71.64 -30.26 65.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.36 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.178 179.963 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -113.24 114.9 27.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.228 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -177.24 156.0 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.175 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.55 69.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.05 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.75 134.07 6.64 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.25 172.21 40.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 99.3 m -143.19 -163.76 1.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -1.107 . . . . 0.0 110.131 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.78 -170.73 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.023 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.86 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.009 -179.543 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.07 55.31 2.17 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 2.0 m-85 -98.12 118.37 34.59 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.486 -1.008 . . . . 0.0 109.243 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.26 123.98 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.32 -179.565 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.518 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.04 131.65 7.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.008 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 20' ' ' LYS . 32.2 p -100.28 149.12 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.02 -28.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.508 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -7.31 38.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 84.35 43.97 6.77 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 62.3 mtp85 -142.78 161.36 38.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -1.054 . . . . 0.0 110.808 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.2 m -89.87 126.09 35.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.473 -0.767 . . . . 0.0 109.925 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.0 ttpp -131.63 130.89 22.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.9 Cg_endo -73.59 132.96 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.695 1.366 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.3 p -73.25 90.47 1.62 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.295 0.569 . . . . 0.0 110.236 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.286 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.157 0.503 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -116.55 163.43 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.135 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -129.4 82.92 2.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.63 79.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.65 143.58 9.64 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -156.71 66.09 0.3 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.3 m -127.15 176.54 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -1.125 . . . . 0.0 110.483 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.168 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.07 -169.24 2.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 110.182 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.58 -95.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.349 -0.845 . . . . 0.0 110.764 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.79 54.41 3.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.168 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.13 124.5 42.71 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.379 -1.071 . . . . 0.0 108.767 179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.1 ttp -99.13 138.63 35.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 110.342 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.51 124.39 23.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 110.207 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.1 p -89.77 146.62 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.819 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.71 -28.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.692 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' THR . 80.6 m-20 -69.76 -13.33 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.81 40.66 4.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.9 mmt180 -134.91 155.66 50.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -1.175 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 76.8 m -94.59 125.98 39.58 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.601 -0.687 . . . . 0.0 110.126 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.95 129.0 23.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.54 135.53 24.32 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.657 1.346 . . . . 0.0 111.937 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.3 p -74.69 102.77 4.73 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.295 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.242 -179.965 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.347 0.594 . . . . 0.0 110.206 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' PHE . 67.2 t30 60.44 93.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER 45.29 -171.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.826 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' PHE . . . 42.73 44.42 3.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.299 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.31 64.54 2.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.93 25.08 67.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 87.0 m -125.65 -169.92 2.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -1.084 . . . . 0.0 110.18 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.079 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.61 -171.63 2.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.27 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.39 -97.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.4 -0.812 . . . . 0.0 111.035 -179.63 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -89.28 53.86 3.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.079 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.9 m-85 -98.55 118.93 36.35 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.427 -1.043 . . . . 0.0 109.066 -179.951 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.88 122.85 42.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.016 . . . . 0.0 110.367 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.24 128.41 9.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 110.269 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.7 143.88 26.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.834 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.87 -28.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.545 -0.722 . . . . 0.0 110.689 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -69.88 -18.92 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 110.123 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.93 43.87 2.01 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 20.8 mtp85 -141.05 162.57 35.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.222 -1.163 . . . . 0.0 110.761 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -94.14 119.66 33.28 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -128.3 132.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.38 134.7 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.852 1.449 . . . . 0.0 111.723 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 22' ' ' THR . 7.5 p -74.77 -47.91 28.38 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.27 0.557 . . . . 0.0 110.401 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.327 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.5 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.151 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -91.3 -169.71 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.24 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 111.017 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.05 55.03 4.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.151 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.49 120.13 38.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.452 -1.028 . . . . 0.0 108.907 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.71 128.41 44.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.413 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.42 122.09 10.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.9 p -89.94 147.93 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.56 -27.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' THR . 26.0 m-20 -70.12 -4.27 20.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 81.8 37.36 16.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.4 mtp-105 -133.17 163.14 29.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.729 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.2 m -95.96 121.28 37.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.563 -0.71 . . . . 0.0 110.024 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.9 mttm -127.91 131.71 23.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.002 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.75 124.73 9.95 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.746 1.393 . . . . 0.0 111.672 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 22' ' ' THR . 14.1 p . . . . . 0 N--CA 1.489 1.481 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.3 m . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.142 0.496 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.098 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -86.59 -170.21 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 111.145 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.09 54.58 2.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.098 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 2.1 m-85 -97.87 119.3 36.23 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.565 -0.962 . . . . 0.0 109.095 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -99.16 123.6 43.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.945 -1.097 . . . . 0.0 110.342 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -46.82 133.96 10.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.378 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.505 ' CG2' ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -100.9 151.28 21.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.8 -29.64 0.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.552 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -70.99 -3.72 21.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.87 40.24 10.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.2 mtp85 -134.67 162.0 33.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.429 -1.042 . . . . 0.0 110.679 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -94.59 129.59 41.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.42 -0.8 . . . . 0.0 110.018 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 2.0 tmmm? -134.29 131.11 20.45 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 109.934 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.3 Cg_endo -73.98 138.89 26.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.789 1.415 . . . . 0.0 111.638 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.0 p . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 121.203 0.525 . . . . 0.0 110.351 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.2 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.186 0.517 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.044 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.08 -170.54 2.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.221 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.85 -98.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.41 -0.806 . . . . 0.0 111.093 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.6 54.96 3.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.044 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.285 1.8 m-85 -98.29 117.62 33.1 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.596 -0.944 . . . . 0.0 109.318 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.3 128.67 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 110.117 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.2 mmt180 -51.62 121.63 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 110.283 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 18' ' ' ARG . 8.3 t -89.84 149.45 22.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.56 -27.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.655 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.53 -5.95 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.09 41.68 8.47 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 29.3 mmt180 -139.9 161.72 36.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -1.184 . . . . 0.0 110.688 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 77.7 m -89.93 116.78 28.24 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.482 -0.761 . . . . 0.0 109.718 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' MET . 59.9 tttt -122.7 130.28 24.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 110.35 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.5 Cg_endo -71.72 130.43 16.98 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.814 1.429 . . . . 0.0 111.634 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 22' ' ' THR . 28.0 p . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.586 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 95.7 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.285 0.564 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.161 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.86 -169.95 2.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.963 . . . . 0.0 110.322 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.41 -97.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.983 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.65 54.07 4.08 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.161 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.6 m-85 -98.02 121.19 39.65 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.431 -1.04 . . . . 0.0 108.966 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.3 ttm -99.04 128.38 45.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 130.29 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 15' ' ' ALA . 63.3 p -94.7 145.53 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.98 -29.01 0.3 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.795 . . . . 0.0 110.603 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.81 -13.73 62.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.09 42.61 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 23.3 mtt180 -138.65 156.64 47.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.805 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -92.7 123.46 36.0 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.1 ttpt -127.67 130.67 23.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.8 Cg_endo -72.71 130.17 15.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.684 1.36 . . . . 0.0 112.055 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 22' ' ' THR . 29.2 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 93.1 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.357 0.599 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.142 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.99 -168.48 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.4 -0.813 . . . . 0.0 110.758 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.35 56.58 2.04 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.142 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.6 m-85 -98.03 120.48 38.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.482 -1.011 . . . . 0.0 109.092 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.11 132.48 44.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 0.0 110.281 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.88 126.21 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 41.9 p -89.86 149.92 22.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.943 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -42.81 -30.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.633 -0.667 . . . . 0.0 110.802 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -14.76 62.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.075 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.03 3.43 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 33.5 mtp180 -137.04 154.92 50.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -1.174 . . . . 0.0 110.77 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.4 m -89.79 118.2 29.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.259 -0.901 . . . . 0.0 110.099 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 10.5 tttt -122.61 130.53 24.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.019 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.0 Cg_endo -71.06 130.34 17.6 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.647 1.341 . . . . 0.0 111.639 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 22' ' ' THR . 5.1 p . . . . . 0 C--N 1.303 -1.438 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.28 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.06 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.8 -172.49 3.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.491 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -42.2 -98.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.432 -0.793 . . . . 0.0 111.133 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.95 52.81 4.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.06 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.9 m-85 -98.41 118.27 34.71 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -1.022 . . . . 0.0 109.139 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.6 ttt -99.12 118.27 35.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.118 . . . . 0.0 110.123 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.5 tpp85 -43.48 127.87 4.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 110.303 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 30.6 p -92.0 146.13 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.46 -26.57 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -9.6 55.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.021 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.55 43.06 5.3 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.7 mtp-105 -142.13 159.74 41.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 0.0 110.756 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.8 m -91.23 121.25 32.82 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.508 -0.745 . . . . 0.0 109.93 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 0.4 OUTLIER -130.0 133.55 25.11 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 110.049 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.661 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.2 Cg_endo -73.69 138.63 26.78 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.805 1.424 . . . . 0.0 111.642 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 10' ' ' GLY . 5.5 p . . . . . 0 N--CA 1.488 1.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 83.9 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.225 0.536 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.116 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.01 -172.05 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.91 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 111.079 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.23 55.4 2.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.116 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.9 m-85 -98.26 120.83 39.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.494 -1.004 . . . . 0.0 108.811 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.3 tpp -99.22 121.23 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 110.31 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -50.27 128.47 19.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 p -89.78 145.99 24.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.856 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.05 -29.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.66 -13.95 62.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 96.53 47.13 2.39 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.5 mmt180 -141.19 154.11 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 81.1 m -91.67 123.53 35.13 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.622 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 10.8 mttt -131.51 131.54 22.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.7 Cg_endo -74.59 139.41 25.4 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.812 1.427 . . . . 0.0 111.797 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.7 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.239 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.1 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.158 0.504 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.084 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.59 -170.82 3.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 110.167 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.419 -0.801 . . . . 0.0 111.0 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.9 3.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.084 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.78 121.11 40.3 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.449 -1.03 . . . . 0.0 109.394 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.17 133.36 43.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 0.0 110.081 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -58.3 126.52 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.342 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 18' ' ' ARG . 1.2 p -90.22 150.38 22.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.87 -30.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -69.85 -9.54 55.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.054 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 89.32 42.33 5.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 8.1 mmm180 -135.36 157.59 46.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -1.108 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.62 117.52 29.81 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 109.95 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 12' ' ' MET . 26.1 mttt -124.71 132.09 24.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.657 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.74 132.57 20.42 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.764 1.402 . . . . 0.0 111.752 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 22' ' ' THR . 9.7 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.671 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 92.7 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.261 0.553 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.1 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.78 -171.67 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.266 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.0 -96.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.481 -0.762 . . . . 0.0 111.046 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.47 3.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.1 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.11 117.21 31.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.479 -1.013 . . . . 0.0 109.089 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' LYS . 2.6 tpt -98.99 123.63 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.983 -1.073 . . . . 0.0 110.115 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.57 128.58 8.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.455 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.8 147.35 23.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.99 -29.12 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -0.75 . . . . 0.0 110.615 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -13.45 62.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.9 41.79 3.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 6.3 mtt180 -139.16 160.0 40.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.135 -1.215 . . . . 0.0 110.712 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 73.9 m -89.2 120.12 30.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.236 -0.915 . . . . 0.0 110.002 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 12' ' ' MET . 66.7 tttt -126.76 130.66 23.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 110.235 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.48 138.53 29.92 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.64 1.337 . . . . 0.0 111.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 10' ' ' GLY . 7.4 p . . . . . 0 N--CA 1.488 1.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.617 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.0 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.246 0.546 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.103 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -88.42 -170.31 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.826 . . . . 0.0 111.033 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.48 55.45 2.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.8 m-85 -98.39 119.81 37.72 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.468 -1.019 . . . . 0.0 109.246 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -98.75 130.1 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.86 -1.15 . . . . 0.0 110.206 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.2 mmt180 -54.55 124.3 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 110.05 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.99 151.31 20.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.91 -27.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.54 -6.46 31.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.854 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.21 41.25 8.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 10.7 mtp180 -140.19 161.85 36.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -1.086 . . . . 0.0 110.847 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.29 127.32 36.68 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 18.1 ttpp -132.49 132.07 22.58 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.912 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.9 Cg_endo -74.04 139.63 27.27 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.698 1.367 . . . . 0.0 111.842 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.298 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 84.7 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.143 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.01 -168.91 1.99 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.31 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.41 -97.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 111.002 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' THR . . . -90.92 54.51 3.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.143 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 1.6 m-85 -97.87 119.33 36.28 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.522 -0.987 . . . . 0.0 109.066 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -98.95 136.51 38.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.935 -1.103 . . . . 0.0 110.407 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.05 127.61 33.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.62 151.56 21.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.12 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 110.872 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -69.81 -11.92 61.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 0.0 110.169 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.55 46.96 3.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 71.1 mtp85 -137.97 155.79 48.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.277 -1.131 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -89.74 121.14 31.62 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.5 tttp -127.09 131.37 23.82 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.938 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.92 138.59 28.78 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.667 1.351 . . . . 0.0 111.831 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.7 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.247 0.546 . . . . 0.0 110.253 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.214 0.531 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.083 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.76 -169.27 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.54 -98.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.417 -0.802 . . . . 0.0 111.096 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.39 56.06 2.39 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.286 2.1 m-85 -97.66 122.68 41.02 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.528 -0.984 . . . . 0.0 109.3 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.7 ttt -99.26 131.2 45.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.97 -1.081 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.68 126.81 28.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -93.9 144.57 25.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.33 -0.856 . . . . 0.0 109.922 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.9 -27.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 -6.96 35.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 87.16 48.55 4.3 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 3.0 mmm180 -147.88 160.9 42.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -1.12 . . . . 0.0 110.78 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.3 m -96.06 126.92 41.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.559 -0.713 . . . . 0.0 109.894 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 28.1 tttp -129.4 130.44 23.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -72.6 135.35 23.87 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.616 1.324 . . . . 0.0 111.892 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 10' ' ' GLY . 14.4 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.184 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 96.8 m . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.218 0.533 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.09 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -99.21 -171.54 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.19 -98.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 111.155 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -87.75 53.76 4.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.09 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.271 1.9 m-85 -98.14 118.99 35.99 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.459 -1.024 . . . . 0.0 109.049 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.5 ttp -99.16 114.17 26.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 110.292 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.16 127.36 4.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 110.096 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 20' ' ' LYS . 1.2 p -89.6 143.94 26.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.69 -27.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.699 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.75 -16.51 63.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.993 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 18' ' ' ARG . . . 99.2 40.14 3.33 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 mmt-85 -137.88 156.26 48.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -1.201 . . . . 0.0 110.777 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.97 118.27 30.22 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.539 -0.726 . . . . 0.0 110.103 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 14' ' ' THR . 1.1 mmtt -126.84 130.83 23.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.6 Cg_endo -72.92 135.88 24.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.816 1.429 . . . . 0.0 111.814 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.0 p . . . . . 0 N--CA 1.488 1.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.27 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.0 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.24 0.543 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.094 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -82.26 -169.73 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.63 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.525 -0.734 . . . . 0.0 110.893 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.54 56.35 1.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.094 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.9 m-85 -98.12 118.01 33.78 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.457 -1.025 . . . . 0.0 109.222 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -98.95 125.74 44.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 110.12 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.56 126.75 8.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.848 . . . . 0.0 110.592 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.3 m -90.28 144.11 26.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.11 -26.79 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.838 . . . . 0.0 110.346 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-20 -70.56 -9.62 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.29 47.03 3.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 7.2 mtt180 -147.54 160.13 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.684 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.07 123.87 34.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 3.7 tttp -130.23 133.62 25.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 109.868 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.4 Cg_endo -73.63 137.04 24.43 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.833 1.438 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 121.311 0.576 . . . . 0.0 110.411 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.4 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.174 0.511 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -87.5 -171.23 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.78 -97.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 111.056 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.12 54.2 4.24 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.267 1.8 m-85 -98.42 119.09 36.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.402 -1.058 . . . . 0.0 108.939 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -99.06 120.4 39.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 110.406 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.62 127.58 4.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 110.294 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -93.12 148.04 22.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.03 -27.49 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.327 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -8.21 47.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 86.69 38.36 8.17 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.3 mmm-85 -134.7 159.45 41.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -1.015 . . . . 0.0 110.605 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.6 m -90.71 122.51 33.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.423 -0.798 . . . . 0.0 109.793 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -129.56 131.0 23.31 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.092 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.5 Cg_endo -73.45 134.35 20.51 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.787 1.414 . . . . 0.0 111.603 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 22' ' ' THR . 8.8 p . . . . . 0 N--CA 1.488 1.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.469 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.0 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.177 0.513 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.981 ' HB3' ' CG ' ' A' ' 11' ' ' PHE . . . -71.12 -174.66 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.26 -99.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.454 -0.779 . . . . 0.0 111.334 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.86 54.39 4.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.981 ' CG ' ' HB3' ' A' ' 8' ' ' ALA 0.278 1.9 m-85 -98.64 118.65 35.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.513 -0.992 . . . . 0.0 109.489 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.1 ttt -99.28 125.89 45.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 110.244 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.79 133.44 4.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 110.312 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -95.08 149.59 21.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.738 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.13 -35.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 17.1 p30 -69.41 -8.31 45.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.143 -0.973 . . . . 0.0 110.406 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.53 46.31 4.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -138.11 162.92 32.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -1.182 . . . . 0.0 110.504 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -91.68 119.98 32.03 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.288 -0.882 . . . . 0.0 109.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -129.06 131.49 23.75 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 110.068 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.666 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.49 134.6 22.75 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.666 1.351 . . . . 0.0 111.795 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 22' ' ' THR . 7.6 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.425 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 89.8 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.08 0.467 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.169 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.05 -170.1 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.983 . . . . 0.0 110.346 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.73 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.469 -0.769 . . . . 0.0 111.155 -179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.56 53.97 4.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.169 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.269 1.8 m-85 -98.03 116.7 30.77 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 108.942 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -99.01 126.39 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 110.435 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -47.55 125.46 8.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.432 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.8 147.24 23.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.64 -29.41 0.49 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.506 -0.746 . . . . 0.0 110.685 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.474 ' OD1' ' HB ' ' A' ' 14' ' ' THR . 25.6 p30 -70.1 -9.54 55.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.15 -0.969 . . . . 0.0 110.04 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 90.08 47.76 3.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.1 mtp85 -146.04 164.0 33.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.182 -1.187 . . . . 0.0 110.624 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.34 118.5 29.88 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.456 -0.777 . . . . 0.0 110.264 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -124.59 127.89 25.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.981 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.0 Cg_endo -72.82 135.42 23.52 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.831 1.437 . . . . 0.0 111.967 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.9 p . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.197 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 91.2 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.224 0.535 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.104 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -79.09 -170.53 2.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.11 -98.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.521 -0.737 . . . . 0.0 111.231 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.62 55.34 3.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.104 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.277 1.7 m-85 -98.24 118.81 35.72 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.589 -0.948 . . . . 0.0 109.171 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.5 tpp -99.48 126.76 45.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.989 -1.069 . . . . 0.0 110.341 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -51.58 120.59 5.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 110.065 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -89.69 146.89 24.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.05 -25.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.499 -0.751 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -69.27 -7.69 39.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 109.801 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 85.04 47.18 5.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -149.58 161.01 43.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -1.129 . . . . 0.0 110.762 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 77.5 m -89.96 118.07 29.25 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.52 -0.738 . . . . 0.0 109.902 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 14.8 tmtt? -123.46 130.47 24.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.114 -0.991 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.99 138.32 30.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.803 1.423 . . . . 0.0 111.809 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.2 p . . . . . 0 C--N 1.302 -1.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.321 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 68.9 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.241 0.543 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.7 -171.99 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.108 -0.995 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.74 -97.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.433 -0.792 . . . . 0.0 111.111 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.43 55.43 2.76 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.018 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.28 2.0 m-85 -98.73 119.88 38.22 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.498 -1.001 . . . . 0.0 109.408 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -98.99 121.88 41.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.997 -1.065 . . . . 0.0 110.255 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.1 mmt180 -46.01 127.61 8.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.564 HG21 ' HD3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -91.98 146.27 23.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.895 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.73 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.404 -0.81 . . . . 0.0 110.522 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 8.4 m-20 -69.86 -9.93 56.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.97 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.33 5.3 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.5 mtp180 -142.57 160.94 39.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -1.227 . . . . 0.0 110.697 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.75 124.39 35.85 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.428 -0.795 . . . . 0.0 110.466 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' HG21 ' A' ' 14' ' ' THR . 2.4 tttp -132.01 134.28 24.99 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.704 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.03 123.27 8.75 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.85 1.447 . . . . 0.0 111.436 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 22' ' ' THR . 15.7 p . . . . . 0 N--CA 1.489 1.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 74.6 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.41 0.624 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.167 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -89.6 -168.19 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.534 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.59 -0.694 . . . . 0.0 111.016 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.5 55.42 3.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.167 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.8 m-85 -98.01 119.17 36.16 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.479 -1.012 . . . . 0.0 109.014 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.2 ttm -99.14 131.23 45.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 110.356 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -52.5 125.14 15.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 110.302 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.89 146.35 24.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.12 -28.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 -2.73 21.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 18' ' ' ARG . . . 83.4 48.67 5.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.4 mtt85 -144.85 162.65 36.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -1.193 . . . . 0.0 110.721 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -95.35 120.71 36.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.426 -0.797 . . . . 0.0 109.831 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.5 tttp -126.61 131.56 23.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.102 -0.999 . . . . 0.0 110.128 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.2 Cg_endo -73.07 133.53 19.84 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.772 1.406 . . . . 0.0 111.492 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.1 p . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.191 0.52 . . . . 0.0 110.541 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.9 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.297 0.57 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -71.32 -170.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.28 -94.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.37 -0.831 . . . . 0.0 110.714 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.48 54.18 3.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.23 119.91 37.73 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.447 -1.031 . . . . 0.0 108.743 179.838 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -99.11 121.42 40.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 0.0 110.711 -179.056 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.73 122.73 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.248 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 147.67 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.882 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.25 -27.71 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.6 -6.42 31.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.8 42.84 6.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.8 mmt85 -142.4 162.43 35.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.155 . . . . 0.0 110.411 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.6 m -95.25 119.47 33.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -122.64 131.26 24.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.165 -0.959 . . . . 0.0 110.157 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.685 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.1 Cg_endo -71.74 132.51 20.32 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.808 1.425 . . . . 0.0 111.776 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 10' ' ' GLY . 15.3 p . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.337 0.589 . . . . 0.0 110.273 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.196 0.522 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.069 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -84.47 -169.4 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.383 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.452 -0.78 . . . . 0.0 111.061 -179.571 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.38 55.49 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.069 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.278 2.3 m-85 -97.74 120.49 38.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.534 -0.98 . . . . 0.0 109.144 -179.736 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.4 ttp -99.14 123.47 43.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.003 -1.061 . . . . 0.0 110.432 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -48.11 130.27 15.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 110.3 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -99.34 143.92 29.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.71 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.558 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 11.5 t0 -69.74 -10.85 59.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 110.028 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 90.34 43.4 4.95 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 17' ' ' GLY . 14.4 mtp180 -142.56 158.22 43.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -1.099 . . . . 0.0 110.66 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -93.49 119.17 32.24 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.467 -0.77 . . . . 0.0 109.734 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 ttmt -123.15 130.83 24.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.684 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.65 139.79 31.56 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.856 1.451 . . . . 0.0 111.987 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 p . . . . . 0 C--N 1.303 -1.449 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 99.3 m . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.164 0.507 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.78 -170.73 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.023 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.86 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.009 -179.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.07 55.31 2.17 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 2.0 m-85 -98.12 118.37 34.59 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.486 -1.008 . . . . 0.0 109.243 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.26 123.98 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.32 -179.565 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.518 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.04 131.65 7.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.008 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 20' ' ' LYS . 32.2 p -100.28 149.12 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.02 -28.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.508 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -7.31 38.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 84.35 43.97 6.77 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 62.3 mtp85 -142.78 161.36 38.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -1.054 . . . . 0.0 110.808 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.2 m -89.87 126.09 35.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.473 -0.767 . . . . 0.0 109.925 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.0 ttpp -131.63 130.89 22.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.9 Cg_endo -73.59 132.96 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.695 1.366 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.3 p . . . . . 0 C--N 1.302 -1.478 0 CA-C-O 121.295 0.569 . . . . 0.0 110.236 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.3 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.168 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.07 -169.24 2.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 110.182 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.58 -95.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.349 -0.845 . . . . 0.0 110.764 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.79 54.41 3.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.168 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.13 124.5 42.71 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.379 -1.071 . . . . 0.0 108.767 179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.1 ttp -99.13 138.63 35.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 110.342 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.51 124.39 23.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 110.207 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.1 p -89.77 146.62 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.819 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.71 -28.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.692 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' THR . 80.6 m-20 -69.76 -13.33 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.81 40.66 4.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.9 mmt180 -134.91 155.66 50.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -1.175 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.8 m -94.59 125.98 39.58 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.601 -0.687 . . . . 0.0 110.126 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.95 129.0 23.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.54 135.53 24.32 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.657 1.346 . . . . 0.0 111.937 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.295 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 87.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.202 0.525 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.079 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.61 -171.63 2.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.27 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.39 -97.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.4 -0.812 . . . . 0.0 111.035 -179.63 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -89.28 53.86 3.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.079 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.9 m-85 -98.55 118.93 36.35 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.427 -1.043 . . . . 0.0 109.066 -179.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.88 122.85 42.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.016 . . . . 0.0 110.367 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.24 128.41 9.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 110.269 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.7 143.88 26.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.834 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.87 -28.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.545 -0.722 . . . . 0.0 110.689 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -69.88 -18.92 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 110.123 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.93 43.87 2.01 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 20.8 mtp85 -141.05 162.57 35.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.222 -1.163 . . . . 0.0 110.761 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -94.14 119.66 33.28 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -128.3 132.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.38 134.7 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.852 1.449 . . . . 0.0 111.723 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 22' ' ' THR . 7.5 p . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 121.27 0.557 . . . . 0.0 110.401 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.446 ' O ' ' OE1' ' A' ' 1' ' ' GLU . 2.5 pp20? . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.244 0.545 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 106.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -162.9 117.11 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.957 . . . . 0.0 110.187 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.7 14.86 4.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.219 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.62 -149.82 18.69 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.06 5.11 61.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.5 m -106.25 176.89 5.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -1.213 . . . . 0.0 110.186 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.151 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -91.3 -169.71 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.24 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.519 -0.738 . . . . 0.0 111.017 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.05 55.03 4.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.151 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.49 120.13 38.38 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.452 -1.028 . . . . 0.0 108.907 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.71 128.41 44.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.413 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.42 122.09 10.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.9 p -89.94 147.93 23.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.56 -27.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' THR . 26.0 m-20 -70.12 -4.27 20.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' THR . . . 81.8 37.36 16.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.4 mtp-105 -133.17 163.14 29.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 0.0 110.729 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.2 m -95.96 121.28 37.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.563 -0.71 . . . . 0.0 110.024 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.9 mttm -127.91 131.71 23.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.197 -0.939 . . . . 0.0 110.002 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.75 124.73 9.95 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.746 1.393 . . . . 0.0 111.672 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 22' ' ' THR . 14.1 p -67.1 -19.39 65.63 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' ASN . 9.2 tt0 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.214 0.531 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' GLU . 65.2 t30 55.28 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.844 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 3.2 t80 64.99 64.46 0.64 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 3' ' ' PHE . . . 179.82 61.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.51 115.77 7.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 173.07 156.46 12.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 76.3 m -142.18 -176.14 4.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -1.165 . . . . 0.0 110.388 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.098 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -86.59 -170.21 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.469 -0.77 . . . . 0.0 111.145 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.09 54.58 2.89 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.098 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 2.1 m-85 -97.87 119.3 36.23 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.565 -0.962 . . . . 0.0 109.095 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -99.16 123.6 43.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.945 -1.097 . . . . 0.0 110.342 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -46.82 133.96 10.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.378 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.505 ' CG2' ' HE2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -100.9 151.28 21.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.8 -29.64 0.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 110.552 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -70.99 -3.72 21.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.11 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.87 40.24 10.87 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.2 mtp85 -134.67 162.0 33.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.429 -1.042 . . . . 0.0 110.679 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 76.6 m -94.59 129.59 41.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.42 -0.8 . . . . 0.0 110.018 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 2.0 tmmm? -134.29 131.11 20.45 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.149 -0.969 . . . . 0.0 109.934 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.3 Cg_endo -73.98 138.89 26.42 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 123.789 1.415 . . . . 0.0 111.638 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.0 p -79.54 -1.12 36.28 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.203 0.525 . . . . 0.0 110.351 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.358 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 1' ' ' GLU . 1.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.257 0.551 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.442 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 39.6 t30 -126.45 164.48 21.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -89.54 171.77 9.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.073 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.07 149.82 40.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.193 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.16 -130.64 6.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -79.25 90.75 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.2 m -141.87 -173.55 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -1.181 . . . . 0.0 110.161 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.044 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.08 -170.54 2.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.221 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.85 -98.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.41 -0.806 . . . . 0.0 111.093 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.6 54.96 3.08 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.044 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.285 1.8 m-85 -98.29 117.62 33.1 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.596 -0.944 . . . . 0.0 109.318 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.3 128.67 45.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 110.117 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.2 mmt180 -51.62 121.63 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 110.283 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 18' ' ' ARG . 8.3 t -89.84 149.45 22.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.56 -27.75 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.485 -0.759 . . . . 0.0 110.655 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.53 -5.95 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.002 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.09 41.68 8.47 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 29.3 mmt180 -139.9 161.72 36.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -1.184 . . . . 0.0 110.688 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 77.7 m -89.93 116.78 28.24 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.482 -0.761 . . . . 0.0 109.718 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 12' ' ' MET . 59.9 tttt -122.7 130.28 24.7 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 110.35 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.5 Cg_endo -71.72 130.43 16.98 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.814 1.429 . . . . 0.0 111.634 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 23' ' ' PHE . 28.0 p -62.5 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.586 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 32.1 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.224 0.535 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 49.2 73.35 0.24 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.219 -0.926 . . . . 0.0 110.18 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.18 104.29 4.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.368 -0.832 . . . . 0.0 110.197 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.21 140.51 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.093 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.87 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.47 77.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 95.7 m -120.78 169.95 9.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -1.107 . . . . 0.0 110.051 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.161 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.86 -169.95 2.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.963 . . . . 0.0 110.322 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.41 -97.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.983 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.65 54.07 4.08 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.161 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.6 m-85 -98.02 121.19 39.65 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.431 -1.04 . . . . 0.0 108.966 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.3 ttm -99.04 128.38 45.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 130.29 38.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 15' ' ' ALA . 63.3 p -94.7 145.53 24.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.98 -29.01 0.3 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.795 . . . . 0.0 110.603 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.81 -13.73 62.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.09 42.61 3.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 23.3 mtt180 -138.65 156.64 47.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -1.121 . . . . 0.0 110.805 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -92.7 123.46 36.0 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' MET . 2.1 ttpt -127.67 130.67 23.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.8 Cg_endo -72.71 130.17 15.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.684 1.36 . . . . 0.0 112.055 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 23' ' ' PHE . 29.2 p -60.52 -92.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' N ' ' OG1' ' A' ' 22' ' ' THR . 18.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 110.226 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 32.0 mm-40 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.222 0.534 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.2 t30 63.86 142.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 140.37 57.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.281 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.63 51.91 1.43 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.859 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.81 157.31 45.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -163.03 89.62 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 93.1 m -123.42 164.54 18.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.157 . . . . 0.0 110.673 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.142 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.99 -168.48 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -0.815 . . . . 0.0 110.211 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -95.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.4 -0.813 . . . . 0.0 110.758 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.35 56.58 2.04 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.142 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.6 m-85 -98.03 120.48 38.51 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.482 -1.011 . . . . 0.0 109.092 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.11 132.48 44.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.942 -1.099 . . . . 0.0 110.281 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.88 126.21 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 41.9 p -89.86 149.92 22.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.943 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -42.81 -30.52 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.633 -0.667 . . . . 0.0 110.802 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.95 -14.76 62.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.075 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.03 3.43 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 33.5 mtp180 -137.04 154.92 50.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -1.174 . . . . 0.0 110.77 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.4 m -89.79 118.2 29.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.259 -0.901 . . . . 0.0 110.099 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 10.5 tttt -122.61 130.53 24.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 110.019 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.0 Cg_endo -71.06 130.34 17.6 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.647 1.341 . . . . 0.0 111.639 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 22' ' ' THR . 5.1 p -78.47 -15.92 58.1 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.28 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.224 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 3' ' ' PHE . 2.2 mp0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.65 67.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 110.312 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -147.75 97.05 2.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.236 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' PHE . . . 48.87 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.965 . . . . 0.0 110.217 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.79 -147.1 4.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 99.03 134.57 8.54 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.7 m -139.53 -179.87 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -1.168 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.06 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.8 -172.49 3.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 110.211 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.491 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -42.2 -98.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.432 -0.793 . . . . 0.0 111.133 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.95 52.81 4.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.06 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.276 1.9 m-85 -98.41 118.27 34.71 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -1.022 . . . . 0.0 109.139 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.6 ttt -99.12 118.27 35.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.91 -1.118 . . . . 0.0 110.123 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.5 tpp85 -43.48 127.87 4.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 110.303 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 20' ' ' LYS . 30.6 p -92.0 146.13 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.46 -26.57 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.812 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -9.6 55.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.021 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.55 43.06 5.3 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.7 mtp-105 -142.13 159.74 41.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -1.158 . . . . 0.0 110.756 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 80.8 m -91.23 121.25 32.82 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.508 -0.745 . . . . 0.0 109.93 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 0.4 OUTLIER -130.0 133.55 25.11 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 110.049 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.661 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.2 Cg_endo -73.69 138.63 26.78 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.805 1.424 . . . . 0.0 111.642 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 10' ' ' GLY . 5.5 p -83.19 42.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.232 0.539 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -113.98 69.2 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 110.205 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.668 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 0.3 OUTLIER 59.66 169.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.359 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 3' ' ' PHE . . . 65.81 155.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.235 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.02 78.61 1.38 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.95 168.23 39.63 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 83.9 m -146.08 -159.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -1.121 . . . . 0.0 110.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.116 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.01 -172.05 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.245 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.91 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 111.079 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.23 55.4 2.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.116 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.9 m-85 -98.26 120.83 39.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.494 -1.004 . . . . 0.0 108.811 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.3 tpp -99.22 121.23 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 110.31 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -50.27 128.47 19.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 p -89.78 145.99 24.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.856 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.05 -29.86 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.66 -13.95 62.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 96.53 47.13 2.39 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.5 mmt180 -141.19 154.11 45.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 81.1 m -91.67 123.53 35.13 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 109.622 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 10.8 mttt -131.51 131.54 22.95 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.7 Cg_endo -74.59 139.41 25.4 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.812 1.427 . . . . 0.0 111.797 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.7 p -80.8 -35.52 32.91 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.239 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.156 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 2.3 mt-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.259 0.552 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 2.5 t-20 65.04 135.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 110.207 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -47.05 120.87 3.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.23 -19.32 3.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.558 ' CA ' ' NH2' ' A' ' 13' ' ' ARG . . . -57.35 -35.34 71.02 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -49.0 160.94 0.68 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.1 m -133.11 177.1 7.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -1.112 . . . . 0.0 110.011 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.084 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -83.59 -170.82 3.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 110.167 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.419 -0.801 . . . . 0.0 111.0 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.9 3.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.084 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.78 121.11 40.3 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.449 -1.03 . . . . 0.0 109.394 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.17 133.36 43.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 0.0 110.081 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.558 ' NH2' ' CA ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER -58.3 126.52 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.342 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 18' ' ' ARG . 1.2 p -90.22 150.38 22.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 110.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.87 -30.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -69.85 -9.54 55.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -0.93 . . . . 0.0 110.054 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 89.32 42.33 5.56 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 8.1 mmm180 -135.36 157.59 46.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -1.108 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 78.2 m -91.62 117.52 29.81 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.39 -0.819 . . . . 0.0 109.95 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 12' ' ' MET . 26.1 mttt -124.71 132.09 24.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.12 -0.988 . . . . 0.0 109.908 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.657 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.74 132.57 20.42 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.764 1.402 . . . . 0.0 111.752 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 22' ' ' THR . 9.7 p -71.78 -27.14 62.75 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.671 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 110.246 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.416 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 3.8 mm-40 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.206 0.527 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 1.5 m-20 -120.94 138.53 54.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -160.38 61.25 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 0.0 110.091 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.95 135.62 52.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.83 157.6 17.48 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -129.77 63.17 0.63 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 92.7 m -145.76 -168.8 3.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -1.123 . . . . 0.0 110.172 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.1 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.78 -171.67 2.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.266 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.0 -96.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.481 -0.762 . . . . 0.0 111.046 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.56 55.47 3.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.1 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.273 1.7 m-85 -98.11 117.21 31.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.479 -1.013 . . . . 0.0 109.089 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' LYS . 2.6 tpt -98.99 123.63 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.983 -1.073 . . . . 0.0 110.115 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.57 128.58 8.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.455 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -90.8 147.35 23.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.99 -29.12 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.5 -0.75 . . . . 0.0 110.615 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -13.45 62.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.9 41.79 3.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 6.3 mtt180 -139.16 160.0 40.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.135 -1.215 . . . . 0.0 110.712 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 73.9 m -89.2 120.12 30.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.236 -0.915 . . . . 0.0 110.002 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 12' ' ' MET . 66.7 tttt -126.76 130.66 23.78 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 110.235 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.48 138.53 29.92 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.64 1.337 . . . . 0.0 111.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 10' ' ' GLY . 7.4 p -76.63 -3.7 39.15 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.617 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.3 t80 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.234 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 56.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.23 0.538 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.0 OUTLIER 174.91 134.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.316 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 1.3 m-85 -114.7 145.39 42.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.212 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 3' ' ' PHE . . . 175.99 46.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.209 -0.932 . . . . 0.0 109.988 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.45 -111.39 0.05 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.04 68.01 3.06 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.0 m -134.13 -175.27 3.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 110.385 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.103 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -88.42 -170.31 2.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.64 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.378 -0.826 . . . . 0.0 111.033 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.48 55.45 2.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.8 m-85 -98.39 119.81 37.72 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.468 -1.019 . . . . 0.0 109.246 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -98.75 130.1 45.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.86 -1.15 . . . . 0.0 110.206 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.2 mmt180 -54.55 124.3 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 110.05 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.99 151.31 20.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.91 -27.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.54 -6.46 31.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.854 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.21 41.25 8.63 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 10.7 mtp180 -140.19 161.85 36.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -1.086 . . . . 0.0 110.847 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.3 m -91.29 127.32 36.68 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 18.1 ttpp -132.49 132.07 22.58 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.912 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.9 Cg_endo -74.04 139.63 27.27 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.698 1.367 . . . . 0.0 111.842 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p -78.73 65.75 4.05 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.298 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.126 179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.207 0.527 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' PHE . 31.2 t-20 -130.74 93.2 3.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ASN . 2.0 t80 43.05 70.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 110.227 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.5 -163.19 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.195 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -117.23 5.71 17.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 146.6 18.34 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 84.7 m -111.96 170.17 8.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.352 -1.087 . . . . 0.0 110.139 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.143 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.01 -168.91 1.99 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.124 -0.985 . . . . 0.0 110.31 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.41 -97.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 111.002 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' O ' HG23 ' A' ' 22' ' ' THR . . . -90.92 54.51 3.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.143 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 1.6 m-85 -97.87 119.33 36.28 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.522 -0.987 . . . . 0.0 109.066 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.6 OUTLIER -98.95 136.51 38.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.935 -1.103 . . . . 0.0 110.407 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -59.05 127.61 33.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.351 -0.843 . . . . 0.0 110.261 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.62 151.56 21.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.12 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.624 -0.672 . . . . 0.0 110.872 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -69.81 -11.92 61.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.182 -0.949 . . . . 0.0 110.169 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.55 46.96 3.1 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 71.1 mtp85 -137.97 155.79 48.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.277 -1.131 . . . . 0.0 110.766 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -89.74 121.14 31.62 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.304 -0.872 . . . . 0.0 110.203 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.5 tttp -127.09 131.37 23.82 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.2 -0.938 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.92 138.59 28.78 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.667 1.351 . . . . 0.0 111.831 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.7 p -72.02 -30.35 65.12 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.247 0.546 . . . . 0.0 110.253 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.201 0.524 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -125.55 75.95 1.52 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ASN . 11.2 m-85 51.63 177.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.64 -23.84 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.059 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.25 166.07 40.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.45 157.27 22.71 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.5 m -124.77 173.03 8.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.338 -1.095 . . . . 0.0 110.015 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.083 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -75.76 -169.27 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.54 -98.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.417 -0.802 . . . . 0.0 111.096 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.39 56.06 2.39 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.286 2.1 m-85 -97.66 122.68 41.02 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.528 -0.984 . . . . 0.0 109.3 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' LYS . 6.7 ttt -99.26 131.2 45.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.97 -1.081 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.68 126.81 28.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 110.353 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -93.9 144.57 25.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.33 -0.856 . . . . 0.0 109.922 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.9 -27.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.379 -0.825 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 -6.96 35.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 87.16 48.55 4.3 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 3.0 mmm180 -147.88 160.9 42.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -1.12 . . . . 0.0 110.78 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 71.3 m -96.06 126.92 41.63 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.559 -0.713 . . . . 0.0 109.894 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 28.1 tttp -129.4 130.44 23.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -72.6 135.35 23.87 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.616 1.324 . . . . 0.0 111.892 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 10' ' ' GLY . 14.4 p -70.49 -19.38 62.94 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.184 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.19 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.239 0.542 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -79.31 57.84 2.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.272 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 59.17 161.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.69 143.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.272 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.88 90.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -164.71 155.32 26.64 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 96.8 m -139.76 -166.99 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.194 . . . . 0.0 110.294 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.09 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -99.21 -171.54 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.328 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.19 -98.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 111.155 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -87.75 53.76 4.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.09 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.271 1.9 m-85 -98.14 118.99 35.99 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.459 -1.024 . . . . 0.0 109.049 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.5 ttp -99.16 114.17 26.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 110.292 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -43.16 127.36 4.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 110.096 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 20' ' ' LYS . 1.2 p -89.6 143.94 26.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.888 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.69 -27.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.699 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.75 -16.51 63.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 109.993 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 18' ' ' ARG . . . 99.2 40.14 3.33 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 mmt-85 -137.88 156.26 48.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -1.201 . . . . 0.0 110.777 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 66.0 m -90.97 118.27 30.22 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.539 -0.726 . . . . 0.0 110.103 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 14' ' ' THR . 1.1 mmtt -126.84 130.83 23.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.086 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.663 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.6 Cg_endo -72.92 135.88 24.09 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.816 1.429 . . . . 0.0 111.814 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.0 p -72.2 56.16 0.33 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.27 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 t80 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.254 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.232 0.539 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -154.64 172.18 18.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.947 . . . . 0.0 110.369 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -50.77 168.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.33 -0.856 . . . . 0.0 110.389 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.36 68.15 1.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.294 -0.879 . . . . 0.0 110.119 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.79 -24.72 9.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.08 83.92 0.47 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 92.0 m -126.3 176.91 6.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.344 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.094 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -82.26 -169.73 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.63 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.525 -0.734 . . . . 0.0 110.893 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.54 56.35 1.98 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.094 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.282 1.9 m-85 -98.12 118.01 33.78 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.457 -1.025 . . . . 0.0 109.222 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -98.95 125.74 44.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.958 -1.089 . . . . 0.0 110.12 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.56 126.75 8.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.848 . . . . 0.0 110.592 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.3 m -90.28 144.11 26.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.11 -26.79 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.838 . . . . 0.0 110.346 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-20 -70.56 -9.62 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.29 47.03 3.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 7.2 mtt180 -147.54 160.13 42.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.684 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.07 123.87 34.31 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 3.7 tttp -130.23 133.62 25.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 109.868 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.4 Cg_endo -73.63 137.04 24.43 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.833 1.438 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 p -78.01 -31.52 50.61 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.311 0.576 . . . . 0.0 110.411 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.31 0.576 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' C ' ' OD1' ' A' ' 2' ' ' ASN . 13.2 p30 -123.19 -176.64 3.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -106.62 98.65 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.06 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.34 95.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.366 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -138.98 -144.39 4.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.73 41.24 0.58 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 94.4 m -120.74 178.92 4.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -1.125 . . . . 0.0 110.222 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -87.5 -171.23 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.78 -97.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.416 -0.802 . . . . 0.0 111.056 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.12 54.2 4.24 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.267 1.8 m-85 -98.42 119.09 36.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.402 -1.058 . . . . 0.0 108.939 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -99.06 120.4 39.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 110.406 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.62 127.58 4.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 110.294 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -93.12 148.04 22.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 110.01 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.03 -27.49 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.327 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -8.21 47.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 18' ' ' ARG . . . 86.69 38.36 8.17 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.3 mmm-85 -134.7 159.45 41.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -1.015 . . . . 0.0 110.605 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.6 m -90.71 122.51 33.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.423 -0.798 . . . . 0.0 109.793 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HG2' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -129.56 131.0 23.31 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.092 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.5 Cg_endo -73.45 134.35 20.51 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.787 1.414 . . . . 0.0 111.603 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 22' ' ' THR . 8.8 p -74.18 -25.39 59.68 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.469 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' OXT' ' CG ' ' A' ' 23' ' ' PHE . 12.1 t80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.182 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.213 0.53 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -124.32 74.8 1.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -64.58 159.12 22.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.16 119.38 10.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.04 -117.3 4.37 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' A' ' 7' ' ' CYS . . . 105.5 169.01 23.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 69.0 m -150.39 -174.56 4.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -1.124 . . . . 0.0 110.133 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.981 ' HB3' ' CG ' ' A' ' 11' ' ' PHE . . . -71.12 -174.66 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -40.26 -99.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.454 -0.779 . . . . 0.0 111.334 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -88.86 54.39 4.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.981 ' CG ' ' HB3' ' A' ' 8' ' ' ALA 0.278 1.9 m-85 -98.64 118.65 35.85 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.513 -0.992 . . . . 0.0 109.489 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.1 ttt -99.28 125.89 45.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 110.244 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -43.79 133.44 4.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 110.312 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -95.08 149.59 21.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.738 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.13 -35.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 17.1 p30 -69.41 -8.31 45.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.143 -0.973 . . . . 0.0 110.406 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.53 46.31 4.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -138.11 162.92 32.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -1.182 . . . . 0.0 110.504 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -91.68 119.98 32.03 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.288 -0.882 . . . . 0.0 109.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -129.06 131.49 23.75 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 110.068 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.666 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.7 Cg_endo -72.49 134.6 22.75 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.666 1.351 . . . . 0.0 111.795 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 22' ' ' THR . 7.6 p -74.7 78.09 2.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.425 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.302 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.208 0.528 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -65.53 147.52 53.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.253 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -144.92 103.96 3.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.22 155.43 1.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.21 133.56 7.28 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 126.46 143.83 5.97 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 89.8 m -131.0 179.75 5.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -1.165 . . . . 0.0 110.091 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.169 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.05 -170.1 2.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.983 . . . . 0.0 110.346 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.73 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.469 -0.769 . . . . 0.0 111.155 -179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -86.56 53.97 4.6 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.169 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.269 1.8 m-85 -98.03 116.7 30.77 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 108.942 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -99.01 126.39 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 110.435 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -47.55 125.46 8.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.432 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.8 147.24 23.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -43.64 -29.41 0.49 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.506 -0.746 . . . . 0.0 110.685 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.474 ' OD1' ' HB ' ' A' ' 14' ' ' THR . 25.6 p30 -70.1 -9.54 55.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.15 -0.969 . . . . 0.0 110.04 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 90.08 47.76 3.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 2.1 mtp85 -146.04 164.0 33.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.182 -1.187 . . . . 0.0 110.624 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 64.6 m -90.34 118.5 29.88 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.456 -0.777 . . . . 0.0 110.264 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -124.59 127.89 25.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.981 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.658 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 33.0 Cg_endo -72.82 135.42 23.52 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.831 1.437 . . . . 0.0 111.967 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.9 p -72.3 -14.42 61.75 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.197 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.2 179.95 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.177 0.513 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 2' ' ' ASN . 8.2 p30 -153.29 74.35 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -87.87 161.31 17.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.918 . . . . 0.0 110.171 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.76 105.54 6.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.47 -63.4 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -178.05 52.2 0.1 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 91.2 m -133.18 171.72 13.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -1.169 . . . . 0.0 110.235 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.104 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -79.09 -170.53 2.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.11 -98.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.521 -0.737 . . . . 0.0 111.231 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.62 55.34 3.45 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.104 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.277 1.7 m-85 -98.24 118.81 35.72 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.589 -0.948 . . . . 0.0 109.171 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.5 tpp -99.48 126.76 45.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.989 -1.069 . . . . 0.0 110.341 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -51.58 120.59 5.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 110.065 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -89.69 146.89 24.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 110.325 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.05 -25.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.499 -0.751 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.4 OUTLIER -69.27 -7.69 39.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 109.801 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . 85.04 47.18 5.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -149.58 161.01 43.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -1.129 . . . . 0.0 110.762 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 77.5 m -89.96 118.07 29.25 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.52 -0.738 . . . . 0.0 109.902 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 12' ' ' MET . 14.8 tmtt? -123.46 130.47 24.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.114 -0.991 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -71.99 138.32 30.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.803 1.423 . . . . 0.0 111.809 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.2 p -69.78 -25.37 63.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.321 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.199 179.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.289 0.566 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -156.22 113.18 3.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.978 . . . . 0.0 110.228 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.96 125.7 38.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.195 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -172.06 -92.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 110.361 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.9 -128.17 1.22 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 100.77 77.07 1.25 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 68.9 m -145.32 -178.18 5.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -1.127 . . . . 0.0 110.033 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -81.7 -171.99 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.108 -0.995 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.74 -97.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.433 -0.792 . . . . 0.0 111.111 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -92.43 55.43 2.76 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.018 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.28 2.0 m-85 -98.73 119.88 38.22 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.498 -1.001 . . . . 0.0 109.408 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 ttp -98.99 121.88 41.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.997 -1.065 . . . . 0.0 110.255 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.1 mmt180 -46.01 127.61 8.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 110.349 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.564 HG21 ' HD3' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -91.98 146.27 23.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.895 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.73 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.404 -0.81 . . . . 0.0 110.522 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 8.4 m-20 -69.86 -9.93 56.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.97 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.33 5.3 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 55.5 mtp180 -142.57 160.94 39.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.114 -1.227 . . . . 0.0 110.697 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 80.3 m -91.75 124.39 35.85 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.428 -0.795 . . . . 0.0 110.466 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' HG21 ' A' ' 14' ' ' THR . 2.4 tttp -132.01 134.28 24.99 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.704 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.675 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.03 123.27 8.75 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.85 1.447 . . . . 0.0 111.436 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' PHE . 15.7 p -67.43 -24.57 65.65 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 22' ' ' THR . 10.4 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.307 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.217 0.532 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 55.02 95.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.115 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.66 125.92 30.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -162.85 178.59 8.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.133 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.47 72.04 1.27 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -112.02 159.5 13.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 74.6 m -122.48 171.94 8.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -1.183 . . . . 0.0 110.446 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.167 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -89.6 -168.19 2.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.534 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.04 -97.51 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.59 -0.694 . . . . 0.0 111.016 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.5 55.42 3.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.167 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.279 1.8 m-85 -98.01 119.17 36.16 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.479 -1.012 . . . . 0.0 109.014 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 20' ' ' LYS . 4.2 ttm -99.14 131.23 45.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.964 -1.085 . . . . 0.0 110.356 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -52.5 125.14 15.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.84 . . . . 0.0 110.302 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.89 146.35 24.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -44.12 -28.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.381 -0.824 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 -2.73 21.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 18' ' ' ARG . . . 83.4 48.67 5.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 14.4 mtt85 -144.85 162.65 36.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -1.193 . . . . 0.0 110.721 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 82.1 m -95.35 120.71 36.06 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.426 -0.797 . . . . 0.0 109.831 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.5 tttp -126.61 131.56 23.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.102 -0.999 . . . . 0.0 110.128 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.677 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.2 Cg_endo -73.07 133.53 19.84 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.772 1.406 . . . . 0.0 111.492 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.1 p -66.44 -34.9 78.98 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.191 0.52 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.256 179.961 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.296 0.569 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -82.24 171.09 14.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -107.15 66.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.8 169.06 4.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.321 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.41 -138.92 4.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . 171.38 110.47 0.24 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.9 m -127.16 161.74 27.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.125 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -71.32 -170.73 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.28 -94.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.37 -0.831 . . . . 0.0 110.714 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.48 54.18 3.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.125 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.23 119.91 37.73 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.447 -1.031 . . . . 0.0 108.743 179.838 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -99.11 121.42 40.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 0.0 110.711 -179.056 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.73 122.73 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.248 179.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 147.67 22.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.882 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -44.25 -27.71 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.469 -0.77 . . . . 0.0 110.468 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.6 -6.42 31.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 110.103 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.8 42.84 6.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.8 mmt85 -142.4 162.43 35.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.155 . . . . 0.0 110.411 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 71.6 m -95.25 119.47 33.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.2 OUTLIER -122.64 131.26 24.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.165 -0.959 . . . . 0.0 110.157 179.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.685 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.1 Cg_endo -71.74 132.51 20.32 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.808 1.425 . . . . 0.0 111.776 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 10' ' ' GLY . 15.3 p -67.93 91.54 0.34 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.337 0.589 . . . . 0.0 110.273 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.237 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.228 0.537 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.23 -176.11 4.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 110.195 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -162.28 107.76 1.23 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.892 . . . . 0.0 110.128 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.83 68.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 110.151 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 3' ' ' PHE . . . 79.08 -115.12 4.04 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.53 39.9 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 77.0 m -138.24 -179.26 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.059 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.069 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -84.47 -169.4 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.383 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.67 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.452 -0.78 . . . . 0.0 111.061 -179.571 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -93.38 55.49 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.069 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.278 2.3 m-85 -97.74 120.49 38.23 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.534 -0.98 . . . . 0.0 109.144 -179.736 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 20' ' ' LYS . 18.4 ttp -99.14 123.47 43.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.003 -1.061 . . . . 0.0 110.432 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -48.11 130.27 15.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 110.3 -179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -99.34 143.92 29.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.814 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -42.71 -27.19 0.16 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.558 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 11.5 t0 -69.74 -10.85 59.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 110.028 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 90.34 43.4 4.95 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 17' ' ' GLY . 14.4 mtp180 -142.56 158.22 43.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -1.099 . . . . 0.0 110.66 -179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -93.49 119.17 32.24 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.467 -0.77 . . . . 0.0 109.734 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 ttmt -123.15 130.83 24.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.684 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 31.9 Cg_endo -72.65 139.79 31.56 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.856 1.451 . . . . 0.0 111.987 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 p -71.64 -30.26 65.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.36 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.178 179.963 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.248 0.547 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -113.24 114.9 27.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -0.856 . . . . 0.0 110.228 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -177.24 156.0 1.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.175 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.55 69.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 110.05 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.75 134.07 6.64 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.25 172.21 40.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' CD ' ' A' ' 13' ' ' ARG . 99.3 m -143.19 -163.76 1.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -1.107 . . . . 0.0 110.131 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -96.78 -170.73 2.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.023 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.519 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -39.86 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.009 -179.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -94.07 55.31 2.17 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.283 2.0 m-85 -98.12 118.37 34.59 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.486 -1.008 . . . . 0.0 109.243 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -99.26 123.98 43.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.32 -179.565 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.518 ' CD ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -45.04 131.65 7.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.008 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 20' ' ' LYS . 32.2 p -100.28 149.12 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -43.02 -28.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.508 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -7.31 38.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 18' ' ' ARG . . . 84.35 43.97 6.77 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 62.3 mtp85 -142.78 161.36 38.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.409 -1.054 . . . . 0.0 110.808 -179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.2 m -89.87 126.09 35.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.473 -0.767 . . . . 0.0 109.925 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 15.0 ttpp -131.63 130.89 22.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.9 Cg_endo -73.59 132.96 18.12 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.695 1.366 . . . . 0.0 111.609 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 10' ' ' GLY . 9.3 p -73.25 90.47 1.62 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.295 0.569 . . . . 0.0 110.236 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.286 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.157 0.503 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -116.55 163.43 16.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -0.863 . . . . 0.0 110.135 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -129.4 82.92 2.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.63 79.86 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.65 143.58 9.64 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' SG ' ' A' ' 19' ' ' CYS . . . -156.71 66.09 0.3 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 88.3 m -127.15 176.54 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -1.125 . . . . 0.0 110.483 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.168 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -90.07 -169.24 2.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 110.182 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -40.58 -95.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.349 -0.845 . . . . 0.0 110.764 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -91.79 54.41 3.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.168 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.7 m-85 -98.13 124.5 42.71 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.379 -1.071 . . . . 0.0 108.767 179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' LYS . 5.1 ttp -99.13 138.63 35.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 110.342 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.51 124.39 23.79 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 110.207 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.1 p -89.77 146.62 24.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.819 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' THR . . . -41.71 -28.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.383 -0.823 . . . . 0.0 110.692 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' THR . 80.6 m-20 -69.76 -13.33 62.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.81 40.66 4.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 4.9 mmt180 -134.91 155.66 50.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -1.175 . . . . 0.0 110.917 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 6' ' ' GLY . 76.8 m -94.59 125.98 39.58 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.601 -0.687 . . . . 0.0 110.126 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.95 129.0 23.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.941 . . . . 0.0 109.988 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.1 Cg_endo -72.54 135.53 24.32 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.657 1.346 . . . . 0.0 111.937 -179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' GLY . 10.3 p -74.69 102.77 4.73 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.295 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.242 -179.965 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.347 0.594 . . . . 0.0 110.206 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' PHE . 67.2 t30 60.44 93.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 110.299 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER 45.29 -171.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.826 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' PHE . . . 42.73 44.42 3.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.299 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.31 64.54 2.45 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.93 25.08 67.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 11' ' ' PHE . 87.0 m -125.65 -169.92 2.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -1.084 . . . . 0.0 110.18 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.079 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . . . -93.61 -171.63 2.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 110.27 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -41.39 -97.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.4 -0.812 . . . . 0.0 111.035 -179.63 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -89.28 53.86 3.88 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.079 ' CD1' ' HB3' ' A' ' 8' ' ' ALA 0.275 1.9 m-85 -98.55 118.93 36.35 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.427 -1.043 . . . . 0.0 109.066 -179.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -98.88 122.85 42.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.016 . . . . 0.0 110.367 -179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -46.24 128.41 9.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.387 -0.821 . . . . 0.0 110.269 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.7 143.88 26.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.834 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -41.87 -28.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.545 -0.722 . . . . 0.0 110.689 -179.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -69.88 -18.92 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 110.123 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.93 43.87 2.01 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 20.8 mtp85 -141.05 162.57 35.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.222 -1.163 . . . . 0.0 110.761 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -94.14 119.66 33.28 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 0.9 OUTLIER -128.3 132.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 32.5 Cg_endo -73.38 134.7 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.852 1.449 . . . . 0.0 111.723 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 22' ' ' THR . 7.5 p -74.77 -47.91 28.38 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.27 0.557 . . . . 0.0 110.401 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.327 -179.945 . . . . . . . . 1 1 . 1 stop_ save_